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Abstract 
Contaminants of emerging concern (CEC) discharged in effluents of wastewater treatment plants 
(WWTPs), not specifically designed for their removal, pose serious hazards to human health and 
ecosystems. Their impact is of particular relevance to wastewater disposal and re-use in agricultural 
settings due to CEC uptake and accumulation in food crops and consequent diffusion into the food-
chain, thus determining unintentional human exposure. This is the reason why the chemical CEC 
discussed in this review have been selected considering, besides recalcitrance, frequency of detection 
and entity of potential hazards, their relevance for crop uptake. Antibiotic-resistant bacteria (ARB) 
and antibiotic resistance genes (ARGs) have been also included as microbial CEC because of the 
potential of secondary wastewater treatment to offer conditions favourable to the survival and 
proliferation of ARB, as well as dissemination of ARGs. Given the adverse effects of chemical and 
microbial CEC, their removal is being considered as an additional design criterion, which highlights 
the necessity of upgrading of conventional WWTPs through the inclusion of more effective 
technologies. In this review, the performance of the currently applied biological treatment methods 
for secondary wastewater treatment is analysed. To this end, technological solutions including 
conventional activated sludge (CAS), membrane bioreactors (MBRs), moving bed biofilm reactors 
(MBBRs), and nature-based solutions such as constructed wetlands (CWs) are compared for the 
achievable removal efficiencies of the selected CEC and their potential of acting as reservoirs of 
ARB&ARGs. With the aim of giving a picture of real systems, this review focuses on data from full-
scale and pilot-scale plants treating real urban wastewater. To achieve an integrated assessment, 
technologies are compared considering also other relevant evaluation parameters of general validity, 
such as investment and management costs, complexity of layout and management, present scale of 
application and need of a post-treatment. The results of their comparison allow the definition of 
design and operation strategies for the implementation of CEC removal in WWTPs, when 
agricultural reuse of effluents is planned.  
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1. Introduction and objectives  
A discussion on the performance of technologies applied in wastewater treatment plants (WWTPs) 
for secondary treatment cannot disregard the presence of contaminants of emerging concern (CEC) 
in wastewaters, when assessing hazards to human health and ecosystems. According to the 
NORMAN network (2017), a CEC is “a substance currently not included in routine environmental 
monitoring programmes and may be candidate for future legislation due to its adverse effects and/or 
persistency”. Also, according to the United States Geological Survey (USGS) CEC include: “any 
synthetic or naturally occurring chemical or any microorganism that is not commonly monitored in 
the environment but has the potential to enter the environment and cause known or suspected 
adverse ecological and/or human health effects” (Klaper and Welch 2011).  
Currently, there is no standardized categorization of CEC, and generally, examined categories 
include among others, pharmaceuticals, personal care products, plasticizers, flame retardants, and 
pesticides. 
The release of CEC to the aquatic environment has been occurring for a long time, but suitable 
detection methods were not available until recently. As a result, nowadays we are able to identify and 
quantify these compounds. The synthesis of new chemicals, or changes in use and disposal of 
existing chemicals can create new sources of CEC into aquatic environments.  
_____________________________________________ 
Abbreviations: A2O, anaerobic–anoxic–oxic; ACTM, Acetamiprid; ARB, antibiotic resistant bacteria; ARGs, antibiotic resistance 
genes; AZM, Azithromycin; BDL, below detection limit; BHT, 2,6-Ditert-butyl-4-methylphenol; BOD, biochemical oxygen demand; 
BTA, Benzotriazole; CAS, conventional activated sludge; CBZ, Carbamazepine; CEC, contaminants of emerging concern; CIP, 
Ciprofloxacin; COD, chemical oxygen demand; CW, constructed wetland; Da, dalton; DCF, Diclofenac; DO, dissolved oxygen; DOC, 
dissolved organic carbon; E1, Estrone; E2, 17-Beta-estradiol; EE2, 17-Alpha-ethynylestradiol; EDG, electron donating functional 
groups; EHMC, 2-Ethylhexyl 4-methoxycinnamate; ENR, Enrofloxacin; ERY, Erythromycin; EWG, electron withdrawing functional 
groups; EU, European Union; F/M, Food to microorganisms ratio; HBCD, Hexabromocyclododecane; HGT, horizontal gene transfer; 
HRT, hydraulic retention time; IntI1, class 1 integron; Kbiol, kinetic reaction rate constant, L/gSS.d; Kd, solid-water partition coefficient, 
L/kgSS; Kow, octanol-water partition coefficient; LCA, life cycle assessment; MBBR, moving bed biofilm reactor; MBR, membrane 
bioreactor; MDR, multi-drug resistance; MF, microfiltration; MLSS, mixed liquor suspended solids; MLVSS, mixed liquor volatile 
suspended solids; MRSA, methicillin-resistant Staphylococcus aureus; N.A., not available; NDMA, N-Nitrosodimethylamine; 
NEREUS, COST Action ES1403 ‘New and emerging challenges and opportunities in wastewater reuse’; NORMAN, Network of 
reference laboratories, research centres and related organisations for monitoring of emerging environmental substances; NSAID, non-
steroidal anti-inflammatory compound; PCPs, personal care products; PE, population equivalent; PFBA, Perfluorobutanoic acid; 
PFHxA, Perfluorohexanoic acid; PFPeA, Perfluoropentanoic acid; QMRA, quantitative microbial risk assessment; q-PCR, quantitative 
polymerase chain reaction; SF CW, surface flow CWs; SMX, Sulfamethoxazole; SRT, sludge retention time; SWWTP, small WWTP 
of < 5.000 PE; TBBPA, Tetrabromobisphenol A; TCS, Triclosan; TCEP, Tris(2-chloroethyl)phosphate; TMP, Trimethoprim; TPs, 
transformation products; TSS, total suspended solids; UF, ultrafiltration; USGS, United States Geological Survey; VRE, Vancomycin-
resistant enterococci; WWTP, wastewater treatment plant. 
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In addition to the occurrence of chemical CEC in water environments, the widespread use and 
misuse of antibiotic residues and their uncontrolled emission in the environment was shown to 
contribute to the proliferation of antibiotic resistant bacteria (ARB) and their associated genes 
(antibiotic resistance genes, ARGs) (Berendonk et al., 2015), whose presence has been also detected 
in urban wastewater (Michael et al., 2013; Rizzo et al., 2013; Li et al., 2014a; Berglund et al., 2015; 
Xu et al., 2015). In this review, the latter are considered as microbial CEC. WWTPs can potentially 
reduce the emission of CEC including antibiotics. However, they also represent an important 
emission source of CEC to the receiving water bodies, due to the incomplete removal of a large 
number of these compounds. Moreover, WWTPs can act as collection points for ARB and 
antimicrobials from a variety of sources (i.e., hospitals, industries, households), consequently 
becoming point sources for environmental dissemination of antibiotic resistance (Pruden et al., 
2013). 
The above-mentioned aspects give an idea of the complexity of the issues arising from the presence 
of CEC in aquatic environments and antibiotic resistance-related problems. A wide spectrum of 
chemical and microbial contaminants with different physicochemical properties, toxicological 
characteristics and degree of potential risk must be managed, requiring suitable responses according 
to the applied treatment process. WWTPs are only partially effective in CEC removal or degradation, 
so these residual CEC are discharged into the environment with treated effluent and excess sludge. In 
an era of water scarcity, the presence of residual amounts of CEC in treated effluents is not only a 
problem for the environment but can also compromise treated wastewater reuse. 
The fate of CEC highly depends on the type of treatment applied at a specific WWTP. There are 
many factors determining the removal of specific classes of contaminants in WWTPs: compound 
chemical properties, plant configuration, hydraulic retention time (HRT), operating conditions (i.e. 
pH, temperature, etc), presence of industrial wastewater, etc. Furthermore, WWTPs commonly need 
to operate on a broad and heterogeneous group of contaminants in a wide range of influent 
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concentrations (varying from 0.001 to 1000 µg/L) [based on Table 2 data]. Therefore, there is a need 
for technological solutions effective for various contaminants and under different operating 
conditions.  
The CEC have attracted the attention of the scientific community in the recent years, with many 
review papers addressing various aspects of CEC. These reviews were either focused on selected 
pharmaceutical compounds such as diclofenac, estrogens or antibiotics (Rivera-Utrilla et al., 2013; 
Vieno and Sillanpää 2014; Polesel et al., 2016; Schröder et al., 2016; Tiedeken et al., 2017) or on the 
selected treatment processes applied for CEC removal. Among these processes, membrane-based 
processes (Siegrist and Joss 2012; de Cazes et al., 2014; Li et al., 2015; Ojajuni et al., 2015; Shojaee 
Nasirabadi et al., 2016; Taheran et al., 2016; Kim et al., 2018), constructed wetlands (CWs) (Dordio 
and Carvalho 2013; Li et al., 2014b; Verlicchi and Zambello 2014; Zhang et al., 2014; Gorito et al., 
2017), biological processes such as conventional activated sludge (CAS), membrane bioreactors 
(MBRs), and bioelectrochemical systems (Verlicchi et al., 2012; Rojas et al., 2013; Vieno and 
Sillanpää 2014; Besha et al., 2017; Cecconet et al., 2017; Grandclément et al., 2017; Tiwari et al., 
2017), and various conventional and advanced processes such as advanced oxidation processes 
(AOPs) or activated carbon (Rivera-Utrilla et al., 2013; Luo et al., 2014; Barbosa et al., 2016; Bui et 
al., 2016; Hamza et al., 2016; Ahmed et al., 2017; Rodriguez-Narvaez et al., 2017; Tiedeken et al., 
2017; Yang et al., 2017) were reviewed. In addition, aspects such as the use of hybrid systems 
(Grandclément et al., 2017), impact on membrane fouling (Besha et al., 2017) sorption and 
biotransformation (Alvarino et al., 2018), geographical distribution (Tran et al., 2018), and 
comprehensive strategies for managing CEC (Talib and Randhir 2017) were also reviewed. 
The gaps that have been identified in these reviews were, among others, related to the significance 
and reliability of the collected CEC removal data being based on synthetic wastewater, small lab-
scale systems, specific industrial wastewaters and/or unsuitable sampling (Taheran et al. 2016, 
Cecconet et al. 2017, Grandclément et al. 2017, Tran et al. 2018). In addition, the need of a cost-
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benefit evaluation of the different treatment technologies (Bui et al. 2016, Grandclément et al. 2017) 
and the lack of information on design for optimum performance (Ahmed et al. 2017) were also 
pointed out. Furthermore, the general lack of knowledge on the occurrence of CEC in WWTP 
effluents and on the efficiency of different treatment methods (Schröder et al. 2016) as well as the 
need for intensification of technology-focused studies for effective and efficient control measures of 
CEC (Tiedeken et al. 2017), have been reported. One of the processes listed was a biofilm process, 
such as the moving bed biofilm reactor (MBBR) (Tran et al. 2018). Finally, due to the increasing 
importance of wastewater reuse as well as to the concern for antibiotic resistance spread from 
WWTPs effluents, there is a clear need to review the microbial CEC, namely ARB&ARGs and 
relevant aspects related to crop uptake.  
To this end, the aim of this review is to address these gaps and specifically: i) to give a picture of real 
applications by focusing on full-scale systems, ii) to analyse the performance of currently applied 
secondary biological treatment technologies (namely CAS, MBR and MBBR) and nature-based 
solutions (namely CWs) for the removal of CEC, iii) to summarize current knowledge on the 
occurrence of antibiotic resistance after biological treatment and on the potential for antibiotic 
resistance spread, and iv) to combine present findings on technical and economic considerations 
regarding the compared technologies as an attempt to provide input for a cost-benefit evaluation. 
Thus, the novelty of this paper predominantly lies in reviewing only full- and pilot-scale plants 
treating real urban wastewater, and including microbial CEC and crop uptake aspects, which are of 
relevance for wastewater reuse. Therefore, the performance of the investigated technologies is 
analysed for a group of target CEC relevant for wastewater reuse, including the compounds reported 
in the EU Watch list (Decision 2015/495/EU, (2015/495/EU) and others, which are relevant for crop 
uptake (Piña et al. 2018). This last factor is essential for reuse, because the CEC present in the 
treated wastewater that is used for irrigation, can accumulate in food crops, being the first link for 
CEC diffusion into the human food-chain, consequently being of relevance given the unintentional 
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human exposure. The prevalence of antibiotic resistance after biological treatment is also analysed to 
search for common trends regions on WWTPs potential for antibiotic resistance spreading, in spite of 
variables that may influence the outcomes, e.g. the operating conditions, plant configuration or 
geographic regions.  
 
2. Selection of CEC 
A list of 33 CEC was compiled for investigation in the present review: compounds were selected 
according to their relevance to wastewater reuse, in particular for potential uptake by crops, public 
health issues and/or environmental safety implications. In addition to this list of organic micro-
contaminants, also ARB&ARGs were included as CEC, an option that is justified by the critical 
relevance of these (micro)biological contaminants to public health and, above all, the recognized 
persistence and self-replication potential of these micro-contaminants in environmental 
compartments. The selection of specific organic and microbial CEC was based on the 
recommendations of the NEREUS COST Action ES 14031, a network of scientists and stakeholders 
interested in urban wastewater reuse from 42 countries. The NEREUS COST Action Working Group 
2 activities, focused on ‘Uptake and translocation of organic micro-contaminants and ARB&ARGs 
in crops’ identified and indicated compounds relevant to crop uptake. This list was combined with a 
list of compounds from the EU Watch List, recommended by the NEREUS COST Action Working 
Group 4, whose activities focused on ‘Technologies efficient/economically viable to meet the current 
wastewater reuse challenges’, due to their environmental and health relevant aspects.  
The following criteria reported in order of priority, were taken into account during the selection of 
the CEC for examination in this review.  
i.Uptake by crops. Once in the agricultural environment, CEC have the potential to be taken up by 
fodder and edible crops. The uptake of pharmaceuticals has been demonstrated by various authors 
                                                          
1 COST Action ES1403 New and emerging challenges and opportunities in wastewater reuse (NEREUS), 
http://www.nereus-cost.eu 
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(Calderón-Preciado et al., 2013; Goldstein et al., 2014; Malchi et al., 2014; Christou et al., 2017; 
Christou et al., 2018). More specifically in a study by Calderón-Preciado et al., (2013), the uptake of 
various CEC and metabolites by lettuce, carrots, potatoes, tomatoes, cucumbers and green beans 
irrigated with reclaimed water has been examined. The results of these studies showed that non-ionic 
pharmaceuticals such as carbamazepine are taken up at higher concentrations compared to ionic 
compounds, by the examined plants. Moreover, the presence of carbamazepine metabolites in the 
leaves of carrots and potatoes at higher concentrations than the parent compound, suggests the 
occurrence of uptake and metabolic breakdown of carbamazepine inside the crop plants.  
ii.Effects on crop production. Plant exposure to CEC may affect plant development, either through 
direct contact and damage, or as the result of the action of pharmaceuticals on plant microbiota and 
soil microorganisms, so having a role in plant-microorganism symbioses and soil nutrient cycling 
(Peñuelas et al., 2013). Ferrari et al., (2003) investigated the effect of carbamazepine, diclofenac and 
clofibric acid residues found in irrigated wastewater on the microalga Pseudokirchinella subcapitata, 
demonstrating a reduction in growth in the algal nutrient solution in the presence of the CEC, at a 
concentration of 10 mg/L. In another study by Eggen et al., (2011), the effect of the uptake of 
metformin, ciprofloxacin and narasin (an anti-coccidial) in carrot and barley were investigated. The 
results showed negative effects on the growth of all plants investigated, when these were grown in 
soil, which contained a concentration of these CEC at 6 to 10 mg kg-1 dry weight. 
iii. Environmental- and human-health concern. The occurrence of CEC in environmental 
compartments has been often associated to a number of biological adverse effects, such as toxic 
effects, endocrine disruption and antibiotic resistance in microorganisms (Luo et al., 2014). Yet, the 
potential effects of CEC remain unclear and in need of further investigations (Ahmed et al., 2017). In 
2015, the European Commission established the EU Watch List (Decision (2015/495/EU) of 17 
substances for monitoring in water. Their inclusion has been justified by their potential to cause 
damage to aquatic environments and to pose a significant risk at European Union level, but for which 
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monitoring data are insufficient to come to a conclusion regarding the actual posed risk. These 
compounds belong to various categories such as estrogenic hormones, non-steroidal anti-
inflammatory compounds (NSAIDs), antibiotics, UV filters and antioxidant compounds, pesticides 
and herbicides. 
iv.Recalcitrance. Recalcitrant compounds, which remain practically unaltered during wastewater 
treatment, require special attention, as they may accumulate in environments receiving treated 
wastewater, and may thus pose a hazard to environmental health. For instance, Jones et al., (2017) 
investigated recently the fate of 95 CEC in 3 full-scale WWTPs after trickling filter treatment 
followed by nitrification, or after activated sludge treatment. Their results indicated that a group of 
compounds were recalcitrant to both treatments, as their removal varied from -58% to 14%. 
Azithromycin (total average removal of 14%), carbamazepine (1%) and estrone (13%) were among 
the recalcitrant CEC. Moreover, the antibiotic erythromycin was found to be recalcitrant during 
biological treatment according to various studies conducted in real wastewater effluents (Yang et al., 
2011; Guerra et al., 2014; Kim et al., 2014; Pasquini et al., 2014), indicating the importance of 
antibiotic monitoring in treated effluent receiving environments.  
v.Frequency of detection. Frequency of detection is an indicator of persistence and tolerance to 
biological treatment. For example, compounds like sulfamethoxazole, carbamazepine, diclofenac, 
estrone and estradiol showed high frequency of detection being present in all treated wastewater 
samples (n=16) of four WWTPs in southern California (Vidal‐Dorsch et al., 2012). Loos et al., 
(2013) found similar results in an EU-wide monitoring survey assessing the occurrence of polar 
chemical contaminants in effluents of 90 WWTPs. Carbamazepine and ciprofloxacin showed a 
frequency of 90%, and sulfamethoxazole and diclofenac were detected with a frequency of 83 and 
89% respectively. Metformin and benzotriazole were also detected in high concentrations exceeding 
1µg/L in the effluent during the screening of the Swiss WWTPs (Margot et al., 2013). 
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The list of the compounds examined in this review, based on the above selection criteria, is shown in 
Table 1.  
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Table 1. Properties, function of selected compounds and justification of their selection for the purposes of this review.  
 
Group Compound Acronym Structure
2 CAS number 
Partition 
coefficient, 
Log KOW 
Molecular 
weight 
[g/mol] 
Function Justification3 
Py
rim
id
in
e 
in
hi
bi
to
r 
an
tib
io
tic
 
Trimethoprim TMP 
 
738-70-5 0.91 290.32 Antibiotic Relevance for crop uptake 
M
ac
ro
lid
e 
an
tib
io
tic
s 
Erythromycin ERY 
 
114-07-8 2.48-3.06 733.93 Antibiotic 
EU Watch List 
(Decision 
2015/495/EU) 
Clarithromycin CLR 
 
81103-11-9 3.16 747.95 Antibiotic 
EU Watch List 
(Decision 
2015/495/EU) 
Azithromycin AZM 
 
83905-01-5 4.02 748.98 Antibiotic 
EU Watch List 
(Decision 
2015/495/EU) 
                                                          
2 http://www.chemspider.com  
3 Selected compounds are also indicators in Swiss water protection act to evaluate effectiveness of advanced treatment of wastewater (Carbamazepine, Clarithromycin, Diclofenac, 
Benzotriazole) or listed as priority hazardous substance in Norway (TCEP, TBBPA, HBCD, Triclosan). 
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Group Compound Acronym Structure
2 CAS number 
Partition 
coefficient, 
Log KOW 
Molecular 
weight 
[g/mol] 
Function Justification3 
Su
lfo
na
m
id
e 
an
tib
io
tic
s 
Sulfamethoxazole SMX 
 
723-46-6 0.89-0.91 253.28 Antibiotic Relevance for crop uptake 
Q
ui
no
lo
ne
 a
nt
ib
io
tic
s 
Enrofloxacin ENR 
 
93106-60-6 1.1 359.39 Antibiotic Relevance for crop uptake 
Ciprofloxacin CIP 
 
85721-33-1 0.28-0.40 331.34 Antibiotic Relevance for crop uptake 
Ph
ar
m
ac
eu
tic
al
s 
Diclofenac DCF 
 
15307-86-5 4-4.5 296.15 
Non-steroidal 
anti-
inflammatory 
agent 
EU Watch List 
(Decision 
2015/495/EU), 
relevance for 
crop uptake 
Metformin MTF 
 
657-24-9 -2.48 129.16 Antidiabetic drug 
Relevance for 
crop uptake 
Carbamazepine CBZ 
 
298-46-4 
85756-57-6 2.45 236.27 
Antiepileptic 
drug 
Relevance for 
crop uptake 
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Group Compound Acronym Structure
2 CAS number 
Partition 
coefficient, 
Log KOW 
Molecular 
weight 
[g/mol] 
Function Justification3 
Lamotrigine LTG 
 
84057-84-1 1.19-2.12 256.09 Anticonvulsant drug 
Relevance for 
crop uptake 
A
nt
im
ic
ro
bi
al
  
ag
en
t 
Triclosan TCS 
 
3380-34-5 5.34 289.54 Antiseptic Relevance for crop uptake 
Es
tro
ge
ns
 
17-Alpha-
ethynylestradiol EE2 
 
57-63-6 3.67-4.12-4.2 296.40 
Synthetic 
hormone 
EU Watch List 
(Decision 
2015/495/EU), 
relevance for 
crop uptake 
17-Beta-estradiol E2 
 
 
50-28-2 
 
3.94-4.01 272.38 Natural hormone 
EU Watch List 
(Decision 
2015/495/EU), 
relevance for 
crop uptake 
Estrone E1 
 
53-16-7 3.13-3.43 270.37 
Natural 
hormone 
(breakdown 
product of E2) 
EU Watch List 
(Decision 
2015/495/EU) 
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Group Compound Acronym Structure
2 CAS number 
Partition 
coefficient, 
Log KOW 
Molecular 
weight 
[g/mol] 
Function Justification3 
In
du
str
ia
l c
he
m
ic
al
s 
2,6-Ditert-butyl-4-
methylphenol BHT 
 
 
128-37-0 3.5-5.1 220.35 
Antioxidant 
(food additive) 
EU Watch List 
(Decision 
2015/495/EU) 
Tris(2-
chloroethyl)phosp
hate 
TCEP 
 
115-96-8 1.44-1.6 285.49 
Flame retardant, 
plasticizer 
Relevance for 
crop uptake 
Tetrabromobisphe
nol A TBBPA 
 
79-94-7 5.3-  5.9 543.87 
Brominated 
flame retardant 
Relevance for 
crop uptake 
Hexabromocyclod
odecane  HBCD 
 
3194-55-6 5.07-5.47 641.69 Brominated flame retardant 
Relevance for 
crop uptake 
Benzotriazole BTA 
 
95-14-7 1.44 119.13 Corrosion inhibitor 
Relevance for 
crop uptake 
N-
Nitrosodimethyla
mine 
(dimethylnitrosam
ine) 
NDMA 
 
62-75-9 -0.57 74.08 
Industrial and 
chlorination by-
product  
Relevance for 
crop uptake 
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Group Compound Acronym Structure
2 CAS number 
Partition 
coefficient, 
Log KOW 
Molecular 
weight 
[g/mol] 
Function Justification3 
Perfluorobutanoic 
acid PFBA 
 
375-22-4 2.82 214.04 
Perfluorinated 
carboxylic acid 
(PFCA) 
Relevance for 
crop uptake 
Perfluoropentanoi
c acid PFPeA 
 
2706-90-3 3.43 264.05 
Perfluorinated 
carboxylic acid 
(PFCA) 
Relevance for 
crop uptake 
Perfluorohexanoic 
acid PFHxA 
 
307-24-4 4.06 314.05 
Perfluorinated 
carboxylic acid 
(PFCA) 
Relevance for 
crop uptake 
Pe
rs
on
al
 c
ar
e 
pr
od
uc
ts 
(P
CP
s)
 2-Ethylhexyl 4-
methoxycinnamat
e 
EHMC 
 
 
5466-77-3 5.8 289.39 290.40 
UV-filter/ 
stabilizer 
EU Watch List 
(Decision 
2015/495/EU) 
N
eo
ni
co
tin
oi
ds
 
Imidacloprid IMI 
 
105827-78-
9/138261-
41-3 
0.57 255.66 Pesticide 
EU Watch List 
(Decision 
2015/495/EU) 
+ relevance for 
crop uptake 
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Group Compound Acronym Structure
2 CAS number 
Partition 
coefficient, 
Log KOW 
Molecular 
weight 
[g/mol] 
Function Justification3 
Thiacloprid THI 
 
111988-49-9 0.73-1.26 252.72 Pesticide 
EU Watch List 
(Decision 
2015/495/EU) 
+ relevance for 
crop uptake 
Thiamethoxam TMX 
 
153719-23-4 -0.13 291.71 Pesticide 
EU Watch List 
(Decision 
2015/495/EU) 
+ relevance for 
crop uptake 
Clothianidin CLO 
 
210880-92-5 0.7 249.68 Pesticide 
EU Watch List 
(Decision 
2015/495/EU) 
+ relevance for 
crop uptake 
Acetamiprid ACTM 
 
135410-20-
7/160430-
64-8 
0.8 222.67 Pesticide 
EU Watch List 
(Decision 
2015/495/EU) 
+ relevance for 
crop uptake 
Pe
sti
ci
de
s 
Methiocarb  
 
2032-65-7 2.92 225.31 Pesticide 
EU Watch List 
(Decision 
2015/495/EU) 
+ relevance for 
crop uptake 
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Group Compound Acronym Structure
2 CAS number 
Partition 
coefficient, 
Log KOW 
Molecular 
weight 
[g/mol] 
Function Justification3 
Oxadiazon  
 
19666-30-9 3.9-4.9 345.22 Herbicide 
EU Watch List 
(Decision 
2015/495/EU) 
+ relevance for 
crop uptake 
Triallate  
 
2303-17-5 4.6 304.66 Herbicide 
EU Watch List 
(Decision 
2015/495/EU) 
+ relevance for 
crop uptake 
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3. Selection of secondary wastewater treatment technologies  
3.1 Criteria for selection  
The examined technologies applied in secondary wastewater treatment were selected according to 
their present level of application at full scale WWTPs, as well as to the state of knowledge of their 
performance for the removal of the selected CEC. The availability of reliable dataset for CEC was 
mandatory to this aim and, unfortunately, not so many data are available for technologies other than 
CAS and MBRs. Accordingly, the attention was mainly focused on these two treatment options. 
However, MBBRs, a potentially effective technology for CEC removal, and CWs, as a valid 
example of nature-based method characterized by easy installation and operation as well as good 
removal efficiencies for several CEC, were also introduced as potential promising alternatives to 
CAS and MBRs.  
 
3.2 Removal mechanisms of CEC for the selected treatment technologies 
For the CAS process, the main removal mechanisms of CEC are biodegradation (intended as 
complete mineralization of the compound) and sorption. Their occurrence and extent depend on the 
operating parameters of the plants i.e. SRT, Food to Microorganisms (F/M) ratio, presence of aerated 
and not aerated zones, pH and temperature. Previous studies found that long SRT have a positive 
effect on the removal of several compounds (Cirja et al., 2017), in particular on hormones and 
antibiotics, which are mainly removed by biodegradation (Strenn et al., 2004). This removal increase 
may be justified by the fact that long SRTs may promote growth of slow growing bacteria with 
various enzymes, which have been shown to have positive effects on removal of various CEC 
including diclofenac, erythromycin and 17α-ethynylestradiol (Suarez et al., 2010; Fernandez-
Fontaina et al., 2012). In addition, varying composition of the solid matrix and different sorption 
capacities due to high SRTs in conjunction with reduced F/M ratio may also increase microbial 
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diversity (Göbel et al., 2007). The influence of HRT has been a subject of discussion as it was 
reported to enhance some compounds degradation (Metcalfe et al., 2003; Gros et al., 2010) as well as 
to have negligible effect on removal of other compounds, e.g. diclofenac (Bernhard et al., 2006). 
Moreover, high biomass concentrations provide higher stability, persistence to shock loads, 
increased contact between microorganisms and pollutants, thus facilitating their biodegradation 
(Cirja et al., 2007; Verlicchi et al., 2012; Trinh et al., 2016a). This may also induce microorganisms 
metabolism of poorly degradable compounds due to relative shortages in biodegradable substances 
associated with reduced F/M ratio (Verlicchi et al., 2012). Suarez et al., (2010) classified CEC based 
on the removal potential under different biological conditions: i) highly removed under aerobic and 
anoxic conditions (e.g., ibuprofen, fluoxetine, natural estrogens); ii) highly removed under aerobic 
but persistent under anoxic conditions (e.g., diclofenac, 17α-ethynylestradiol, erythromycin), and iii) 
refractory to biological transformation (e.g., sulfamethoxazole, carbamazepine). Finally, temperature 
of wastewater as well as seasonal temperature changes play a role in the removal of CEC, as better 
removal is obtained at temperatures of 15–20°C compared to below 10°C (Vieno et al., 2005; 
Castiglioni et al., 2006).  
Biodegradation and sorption are also the main CEC removal mechanisms in MBRs (Radjenović et 
al., 2008; Verlicchi et al., 2012; Luo et al., 2014; Li et al., 2015). This is because of the low 
molecular size of most CEC, typically below 1000 dalton, which leads to no direct physical retention 
on MF (microfiltration) and UF (ultrafiltration) membranes (retention size of ca. 10 000-500 000 
Da). However, the sludge deposits formed on the membrane surface can act as an additional barrier 
contributing to the removal of CEC (Li et al., 2015). Furthermore, the hydrophobicity of CEC 
influences CEC sorption and removal. The removal is improved when the compound is significantly 
hydrophobic (log Kow>3), such as the case of diclofenac, EE2, E2, EHMC, azithromycin, triallate 
and oxadiazon (Phan et al., 2014). Otherwise, sorption onto biosolids is limited and biodegradation is 
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the dominant removal mechanism. Variable removal efficiencies have been reported in MBRs for 
persistent compounds, including diclofenac and carbamazepine, which have low kbiol and low Kd 
values (Wijekoon et al., 2013). Despite the agreement on the higher removal of hydrophobic 
compounds and containing electron donating functional groups (EDG) compared to the compounds 
with opposite characteristics by MBRs, there is still a lack of understanding on the complete causes 
of removal of CEC and their transformation products (TPs) in MBRs (Reif et al., 2013). Concerning 
the effect of the operating parameters on CEC removal in MBRs, similarly to CAS, Li et al., (2015) 
concluded that higher SRT, lower pH, higher nitrogen loading rate, and anoxic conditions favour 
removal of some pharmaceutical micropollutants in MBRs. 
In CWs, a combination of physical, chemical, and biological processes may occur simultaneously 
and contribute to CEC removal. These include photodegradation, volatilization, phytoremediation, 
adsorption and sedimentation, as well as microbial biodegradation (Matamoros et al., 2005; Hijosa-
Valsero et al., 2010a; Reyes-Contreras et al., 2012; Li et al., 2014b). First, photodegradation is an 
important removal pathway for CEC in CW systems with free water surface, i.e. surface flow CWs 
(Andreozzi et al., 2003). Seasonal variations leading to lower light availability, lower light intensity, 
or stronger light attenuation with increasing water depth will reduce photodegradation efficiency in 
aquatic systems (Buser et al., 1998; Matamoros et al., 2008). These parameters will also affect 
removal of compounds with high volatilization potential. Secondly, the plants in CWs can directly 
uptake and translocate CEC (Dordio et al., 2009; Dordio et al., 2010; Hijosa-Valsero et al., 2010b; 
Hijosa-Valsero et al., 2011a; Carvalho et al., 2014). This uptake and translocation is most likely 
driven by diffusion, as no specific transporters exist within plants to move CEC into plant tissues 
(Dordio and Carvalho 2013). In addition, CEC can be transformed to less toxic compounds during 
metabolization in plants (Salt et al., 1998; He et al., 2017). Furthermore, the substrate of a CW (the 
CWs filling) can support growth of microorganisms and plants, and can adsorb different compounds, 
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including CEC. Substrates with a greater adsorption capability for CEC can significantly enhance 
CEC removal (Dordio et al., 2007; Bui and Choi 2010; Conkle et al., 2010).  
In MBBRs, the main removal mechanism is biodegradation. The amount of CEC eliminated with 
excess sludge withdrawal is lower than with CAS system as MBBRs work at a very low organic 
load. As mentioned in the CAS section above, SRT is as an important operational parameter for the 
removal of several micropollutants (Strenn et al., 2004). The agglomeration of bacteria as a biofilm 
and the retention of the support media for the attached growth process in the biological reactor 
results in long SRT. The geometry of the support media for bacterial growth allows the development 
of thin (~50 µm) or thick (> 200 µm) biofilms with different density, biodiversity composition, 
microbial activity and redox conditions (Torresi et al., 2017). Thin biofilms result in high nitrifying 
activities (enhancement of biotransformation kinetic of diclofenac, sulfamethoxazole, erythromycin, 
atenolol) while thick biofilms have a high bacterial biodiversity (more than 60% of target 
compounds showed higher biotransformation kinetics). Thus, combining the more suitable media 
and operational conditions lead the MBBR process to enhance specific or overall CEC elimination.  
 
4. Effects of secondary treatments on chemical CEC fate 
4.1 Influent characterization 
To evaluate the performance of the analyzed technologies it is important to have information on the 
CEC concentrations present in WWTPs influents. These concentrations are relevant for the 
determination of the efficiency of the applied technology. Data available for the selected compounds 
are reported in supplementary material Table SM1, while the range of concentrations is reported in 
Table 2. A variable range, from a few ng/L to several µg/L, is observed, which makes necessary to 
evaluate, case by case, the effluent quality and the related CEC emissions.  
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Table 2. Concentration range of the selected CEC in municipal wastewater before treatment.  
Category Concentration 
range (ng/L) 
Reference 
Antibiotics 
Trimethoprim 13-6000 (Gobel et al., 2005; Perez et al., 2005; Leung et al., 2012; Senta et al., 
2013; Guerra et al., 2014; Carvalho and Santos 2016; Botero-Coy et 
al., 2018) 
Erythromycin 17-320 (Yang and Carlson 2004; Gobel et al., 2005; Gros et al., 2006; 
Papageorgiou et al., 2016; Botero-Coy et al., 2018) 
Clarithromycin BDL-8000 (Loganathan et al., 2009; Margot et al., 2013; Birošová et al., 2014; 
Guerra et al., 2014; Tran et al., 2018) 
Azithromycin BDL-6810 (Gobel et al., 2005; Loganathan et al., 2009; Margot et al., 2013; 
Senta et al., 2013; Botero-Coy et al., 2018) 
Sulfamethoxazole BDL-3100  (Gobel et al., 2005; Perez et al., 2005; Gros et al., 2006; Margot et al., 
2013; Zhou et al., 2013; Guerra et al., 2014; Papageorgiou et al., 
2016) 
Enrofloxacin 3-100 (Watkinson et al., 2007; Ghosh et al., 2009; Birošová et al., 2014) 
Ciprofloxacin 15-3350 (Watkinson et al., 2007; Margot et al., 2013; Zhou et al., 2013; He et 
al., 2015; Botero-Coy et al., 2018)  
Other pharmaceuticals/antimicrobials  
Diclofenac  50-4114 (Clara et al., 2005b; Gros et al., 2006; Margot et al., 2013; Sari et al., 
2014) 
Metformin BDL->10000 (Margot et al., 2013; Kosma et al., 2015)  
Carbamazepine 54-1850 (Clara et al., 2005b; Nakada et al., 2006; Margot et al., 2013) 
Lamotrigine 13-1110 (Bollmann et al., 2016; Zonja et al., 2016) 
Triclosan  500- 6100 
 
(Lindstrom et al., 2002; Singer et al., 2002; Halden and Paull 2005; 
Ying and Kookana 2007) 
Industrial Chemicals 
2,6-Ditert-butyl- 
4-methylphenol(BHT) 
2420 (Liu et al., 2015) 
Tris(2-chloroethyl) 
 phosphate (TCEP) 
180-439 (Meyer and Bester 2004; Ryu et al., 2014; Zeng et al., 2015; Cristale 
et al., 2016) 
Tetrabromobisphenol A 1.22x10-4-41  (Morris et al., 2004; Potvin et al., 2012; Kim et al., 2016) 
Hexabromocyclododecane  1.2-11 (Vieno and Toivikko 2014; De Guzman 2016) 
24 
 
(HBCD)  
Benzotriazole (BTA) 1119- 44000  (Reemtsma et al., 2010; Liu et al., 2012; Asimakopoulos et al., 2013) 
N-Nitrosodimethylamine  
(dimethyl-nitrosamine) 
183-8230 (Yoon et al., 2011; Wang L. 2014) 
Perfluorobutanoic acid  
(PFBA) 
0.05-265 (Zhang et al., 2013; Zhang et al., 2015a) 
Perfluoropentanoic acid  
(PFPeA) 
0.5- 1520 (Lin et al., 2010; Ma and Shih 2010; Pan et al., 2011; Kim et al., 
2012; Zhang et al., 2013; Zhang et al., 2015a) 
Perfluorohexanoic acid 
(PFHxA) 
 1-348 (Lin et al., 2010; Ma and Shih 2010; Kim et al., 2012; Zhang et al., 
2013; Zhang et al., 2015a) 
Estrogens 
Estrone (E1) 11.6-224 (Zhou et al., 2012; Margot et al., 2013; Ekpeghere et al., 2018) 
17β-Estradiol (E2) 3.7-140 (Zhou et al., 2012; Margot et al., 2013; Ekpeghere et al., 2018) 
17α-Ethynylestradiol (EE2) BDL-330 (Zhou et al., 2012; Margot et al., 2013; Ekpeghere et al., 2018) 
Personal care products 
2-Ethylhexyl  
ethoxycinnamate (EHMC) 
23-1290 (Tsui et al., 2014; Ekpeghere et al., 2016) 
Neonicotinoids 
Imidacloprid 54.7 (Sadaria et al., 2016) 
Thiacloprid BDL (Sadaria et al., 2016) 
Thiamethoxam BDL (Sadaria et al., 2016) 
Clothianidin 149.7 (Sadaria et al., 2016) 
Acetamiprid 3.7 (Sadaria et al., 2016) 
 
Pesticides 
Methiocarb N.A.   
Oxadiazon N.A.  
Triallate N.A.  
Legend: BDL - below detection limit; N.A. – not available. 
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4.2 Conventional activated sludge 
Data available on the removal efficiencies detected for CAS are mainly related to pharmaceuticals 
(by far the most investigated class of CEC), personal care products and endocrine disruptor 
compounds.     
The high concentrations especially for some pharmaceuticals reported in Table 2 show that, even 
when high removal efficiencies are achieved, consistent residual amounts will remain in the effluent 
which can significantly impact the receiving water body or compromise treated wastewater reuse.  
Table 3 shows an overview of the data on the removal efficiencies for the selected CEC in secondary 
treatment by CAS. Reported data are mainly referring to the last decade. A high variability in the 
removal efficiencies is observed, which can be explained with the seasonal variation of the plant 
performance and the variability of the CEC influent concentrations. Moreover, the presence of very 
low concentrations, which, in some cases, are close or below detection limits, makes the evaluation 
of a precise removal efficiency difficult. A more detailed and extended table (Table SM2) on the 
removal efficiencies is included in supplementary material. 
According to the results of a Canadian survey of 18 WWTPs (Metcalfe et al., 2003), primary 
treatment resulted in minimal reductions of CEC, while better results were observed for the 
secondary. It is worth noting that in several cases negative removals were observed, which are 
indicative of formation of parent compounds e.g., through de-conjugation, or accumulation of the 
substances during treatment, especially if sampling was carried out during non-steady-state plant 
operation. In addition, effluent quality can be worsened by the formation of intermediate products in 
case of partial biodegradation.  
Among the selected pharmaceuticals, the neutral drug carbamazepine was poorly removed by the 
secondary treatment. It resulted as one of the most critical compounds, among the monitored 
26 
 
pharmaceuticals, in all countries. This behaviour may be due to its hydrophilic nature (logKow <3) 
and chemical stability (Nakada et al., 2006). Similar behaviour is observed for lamotrigine which, in 
two recent studies (Bollmann et al., 2016; Zonja et al., 2016), showed a consistent concentration 
increase in the effluent.  
For the selected antibiotics, highest removal efficiencies were detected for ciprofloxacin and 
sulfamethoxazole, while the other antibiotics are characterized by quite low removals.  
As regard as the estrogenic compounds, higher removal efficiencies were observed for the hormone 
17β-estradiol than for estrone (Zhou et al., 2012). Secondary treatment can reach removal 
efficiencies ≥ 90% for estrogenic compounds but only in WWTPs performing nitrification or 
nitrogen removal (Andersen et al., 2003). This is because high HRT and SRT are required for 
efficient estrone removal, as it is confirmed by Margot et al., (2013) reporting the data of the 
Lausanne plant (operated without nitrification) where the removal of 17β-estradiol and estrone was 
91% and 58±31%, respectively. 
Not many data are available for EHMC removal and neonicotinoids in CAS. Tsui et al., (2014) for a 
WWTP operated with Modified Ludzack Ettinger configuration, reported low to moderate removal 
of EHMC, i.e., 30% in the wet season and 55% in the dry season, which was negatively affected by 
seasonal variation of the influent load and temperature during the wet season. As regard as 
neonicotinoids, Sadaria et al., (2016) in a recent study on a WWTP measured low removal 
efficiencies of 11-18% for the selected compounds except for thiacloprid and thiamethoxam showing 
negligible concentration (BDL) in the influent and effluent.  
Pesticides are among the organic contaminants most investigated in the aquatic environment, but 
their occurrence and fate in WWTPs has been rarely investigated, perhaps because these compounds 
are of agricultural rather than of urban origin. In spite of this, wastewaters represent one of the main 
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routes of pesticide contamination into the environment (Cahill et al., 2011) and several sources 
justifying the presence of pesticides in WWTPs were identified. They are extensively applied in 
grass-maintenance, in industrial vegetation control for electric utilities, roadways, railroads, 
pipelines, and in non-agricultural crops such as commercial forestry and horticulture (Barceló D 
2003). For these reasons, to our best knowledge data on these specific compounds in the target list 
are not available in literature. In any case, it is worth noting that the reported removals of pesticides 
in full-scale WWTPs are generally poor with presence, in some cases, of increased concentrations in 
the effluent (Kock-Schulmeyer et al., 2013).  
An extremely variable behaviour in WWTPs is observed for industrial chemicals with almost 
complete/good removal for instance for BHT, TBBP-A, BTA, and wide range of removal efficiency 
for other compounds such as PFCAs (PFBA, PFPeA, PFHxA) and NDMA. This finding is expected 
if we consider the diversity of the chemical structure, which as pointed out in the paragraph 4.1 
consistently affects the removal mechanisms.   
From the data analysis of CAS, we can conclude that CEC removal efficiency is strongly affected by 
HRT and SRT. To give a general idea of the limit values, according to Metcalfe et al., (2003), worst 
performance is observed in plants having HRT ≤ 7 hr and SRT ≤ 1.9 d.  
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Table 3. Range of the removal efficiencies of the selected CEC in CAS plants  
Category Removal 
efficiency (%) 
Reference 
Antibiotics 
Trimethoprim 31 (Gobel et al., 2005) 
Erythromycin (-14)-100  (Yang and Carlson 2004; Gobel et al., 2005; Gros et al., 2006) 
Clarithromycin 37 (Margot et al., 2013) 
Azithromycin 11-44 (Gobel et al., 2005; Loganathan et al., 2009; Margot et al., 2013) 
Sulfamethoxazole 35-84 (Gobel et al., 2005; Margot et al., 2013; Zhou et al., 2013) 
Enrofloxacin ~ 0 (Watkinson et al., 2007) 
Ciprofloxacin 63-90 (Margot et al., 2013; Zhou et al., 2013) 
Other pharmaceuticals/antimicrobials 
Diclofenac  <0-81 
 
(Clara et al., 2005b; Margot et al., 2013; Luo et al., 2014; Sari et 
al., 2014) 
Metformin 78-99 (Kosma et al., 2015) 
Carbamazepine (-90)-(-3)  
 
(Metcalfe et al., 2003; Clara et al., 2005b; Nakada et al., 2006; 
Margot et al., 2013) 
Lamotrigine (-361)-(-38) (Bollmann et al., 2016; Zonja et al., 2016) 
Triclosan 34-99  (Lindstrom et al., 2002; Singer et al., 2002; Halden and Paull 2005; 
Ying and Kookana 2007) 
Industrial Chemicals 
2,6-Ditert-butyl-4-
methylphenol(BHT) 
89 (Liu et al., 2015) 
Tris(2-chloroethyl) 
phosphate (TCEP) 
(-106)-0 (Meyer and Bester 2004; Ryu et al., 2014; Zeng et al., 2015; 
Cristale et al., 2016) 
Tetrabromobisphenol A 10-100 (Potvin et al., 2012; Kim et al., 2016) 
Hexabromocyclododecane 
(HBCD) 
0-86 (Vieno and Toivikko 2014; De Guzman 2016)  
Benzotriazole (BTA) 30-91 (Reemtsma et al., 2010; Liu et al., 2012; Asimakopoulos et al., 
2013) 
N-Nitrosodimethylamine 
(dimethyl-nitrosamine)* 
(NDMA) 
5-84  (Yoon et al., 2011; Wang L. 2014) 
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Perfluorobutanoic acid 
(PFBA) 
(-108)-65 (Zhang et al., 2013; Zhang et al., 2015a) 
Perfluoropentanoic acid 
(PFPeA) 
(-400)-50 (Pan et al., 2011; Kim et al., 2012; Zhang et al., 2013; Zhang et al., 
2015a) 
Perfluorohexanoic acid 
(PFHxA) 
(-226)-39 (Kim et al., 2012; Zhang et al., 2013; Zhang et al., 2015a) 
Estrogens 
Estrone (E1) 58-81 (Zhou et al., 2012; Margot et al., 2013) 
17β-Estradiol (E2) 91-96 (Zhou et al., 2012; Margot et al., 2013) 
17α-Ethynylestradiol 
(EE2) 
>18-94 
 
(Zhou et al., 2012; Margot et al., 2013) 
Personal care products 
2-Ethylhexyl  
ethoxycinnamate (EHMC) 
30-55 (Tsui et al., 2014) 
Neonicotinoids 
Imidacloprid 11  (Sadaria et al., 2016) 
Thiacloprid BDL in/out (Sadaria et al., 2016) 
Thiamethoxam BDL in/out (Sadaria et al., 2016) 
Clothianidin 13 (Sadaria et al., 2016) 
Acetamiprid 18 (Sadaria et al., 2016) 
Pesticides 
Methiocarb 
Oxadiazon 
Triallate 
N.A. 
N.A. 
N.A. 
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4.3 Membrane bioreactors 
The MBR is a process that integrates biodegradation of contaminants by activated sludge, with direct 
solid-liquid separation by membrane filtration, i.e. through a MF or UF membrane. The MBR 
technology is currently widely accepted as an alternative key technology to CAS treatment utilised in 
urban WWTPs and water reuse applications. The wide use of MBRs has been attributed to its notable 
advantages, such as high quality of produced water, high biodegradation efficiency of contaminants, 
and an overall smaller footprint (Judd, 2015).  
This technology permits bioreactor operation with considerably higher mixed liquor suspended 
solids (MLSS) concentration than CAS systems, which are limited by sludge settling phenomena. 
The process in MBRs is typically operated at MLSS in the range of 8–12 g/L, while CAS is operated 
in the range of 2–3 g/L (Melin et al. 2006), thus providing high biological activity per unit volume. 
This feature favours the generation of slow-growing bacteria, which have the ability to degrade 
certain biologically-recalcitrant organic and inorganic pollutants (Clouzot et al., 2011). Therefore, 
despite not been designed to remove organic and inorganic micropollutants, MBRs may provide 
effective removal of some of the CEC. Early studies reported improved CEC removal with MBRs 
compared to CAS, as MBRs operate at a higher SRT than CAS, thus enhancing contaminant 
biodegradability (Holbrook et al., 2002; Stephenson et al., 2007). However, when MBRs and CAS 
were compared under similar operating conditions (i.e., SRT, temperature) in the removal of CEC, 
no significant differences were observed (Joss et al., 2006; Bouju et al.m 2008; Weiss and 
Reemtsma, 2008; Abegglen et al., 2009). Therefore, it was postulated that MBRs and CAS systems 
may perform similar as long as the same operating conditions are provided, although MBRs may 
outperform CAS at higher SRT. This is because CEC are generally highly soluble and relatively 
small compounds, typically below 1000 Dalton, which can freely pass through the membranes used 
in MBR systems thereby indicating that those membranes have no direct impact on the removal of 
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CEC (Snyder et al., 2007). Others report that MBRs are able to effectively remove a wide spectrum 
of CEC including compounds that are not eliminated during CAS processes (Radjenović et al., 2009; 
Luo et al., 2014).  
Overall, the potential to achieve slightly improved removal of CEC in MBRs compared to the CAS 
process, is attributed to: (1) complete retention of suspended and colloidal particles to which many of 
the CEC sorb or are entrapped at the cake layer developed on the membrane surface; (2) ability to 
operate under longer SRT providing additional biological transformation of CEC (via diversification 
of microorganisms metabolic activity in response to the lower sludge loading with bulk organics) 
and more diversified microbial community (e.g. nitrifying bacteria); and (3) higher biomass 
concentrations providing higher degradation rate. All of the aforementioned factors may provide 
additional removal mechanisms of CEC. On the other hand, the advantage of operating MBRs at 
very high SRT to promote the biodegradation of recalcitrant compounds is usually offset by the 
increased operating costs associated with the higher oxygen requirements of biomass. Hence, despite 
significant research attention in the past years, general consensus regarding the MBRs and CAS 
potential to remove CEC has not been reached yet.  
Table 4 summarizes the removal efficiency of the selected CEC (Hernando et al., 2007; Onesios et 
al., 2008; Petrovic et al., 2009; Tambosi et al., 2010b; Verlicchi et al., 2012; Reif et al., 2013; Rojas 
et al., 2013; de Cazes et al., 2014; Luo et al., 2014; Eggen and Vogelsang 2015; Li et al., 2015). The 
overview excludes the experimental work carried out using lab-scale MBR systems fed with 
synthetic wastewater, and reports only results from full-scale MBRs or pilot-scale MBRs located at 
the premises of the WWTPs and fed with real wastewater. Until now, only a limited number of the 
studies were performed on full-scale MBR installations (Sui et al., 2011; Trinh et al., 2012b; 
Oosterhuis et al., 2013; Fenu et al., 2015; Trinh et al., 2016b). 
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A more detailed table including the operating conditions of the WWTPs and on the type of 
wastewater and sampling methods is reported in the supplementary material section (Table SM3). 
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Table 4. Range of the removal efficiencies of the selected CEC in MBRs   
Category Removal 
efficiency (%) 
References 
Antibiotics 
Trimethoprim <0-99 (Göbel et al., 2007; Kim et al., 2007; Snyder et al., 2007; Tambosi et al., 
2010a; Sahar et al., 2011a; Sahar et al., 2011b; Sahar et al., 2011c; Sui et 
al., 2011; Schröder et al., 2012; Trinh et al., 2012b; Qi et al., 2015; 
Arriaga et al., 2016; Tran et al., 2016; Trinh et al., 2016b; Arola et al., 
2017; Park et al., 2017) 
Erythromycin 4-99 (Kim et al., 2007; Radjenovic et al., 2007; Snyder et al., 2007; Barceló et 
al., 2009; Radjenovic et al., 2009; Xue et al., 2010; Sahar et al., 2011a; 
Sahar et al., 2011b; Sahar et al., 2011c; Dolar et al., 2012; Malpei et al., 
2012; Kim et al., 2014; Qi et al., 2015; Arriaga et al., 2016; Mamo et al., 
2016; Tran et al., 2016) 
Clarithromycin <0-99 (Göbel et al., 2007; Sahar et al., 2011a; Sahar et al., 2011b; Sahar et al., 
2011c; Dolar et al., 2012; Malpei et al., 2012; Kim et al., 2014; Qi et al., 
2015; Arriaga et al., 2016; Mamo et al., 2016; Tran et al., 2016; Park et 
al., 2017) 
Azithromycin 5-90 (Göbel et al., 2007; Dolar et al., 2012; Kim et al., 2014; Mamo et al., 
2016; Tran et al., 2016) 
Sulfamethoxazole 0-90 (Kreuzinger et al., 2004; Clara et al., 2005b; Joss et al., 2005; Göbel et al., 
2007; Kim et al., 2007; Radjenovic et al., 2007; Barceló et al., 2009; 
Radjenovic et al., 2009; Le-Minh et al., 2010:Snyder, 2007 #1635; 
Tambosi et al., 2010a; Sahar et al., 2011a; Sahar et al., 2011b; Sahar et 
al., 2011c; Dolar et al., 2012; García Galán et al., 2012; Schröder et al., 
2012; Trinh et al., 2012b; Kim et al., 2014; Fenu et al., 2015; Phan et al., 
2015; Qi et al., 2015; Tran et al., 2016; Trinh et al., 2016b; Park et al., 
2017) 
Enrofloxacin <LOQ-56 (Baumgarten et al., 2007; Park et al., 2017) 
Ciprofloxacin 15-94 (Baumgarten et al., 2007; Malpei et al., 2012; Kim et al., 2014; Tran et 
al., 2016; Park et al., 2017) 
Other pharmaceuticals/antimicrobials 
Diclofenac <0-87 (Clara et al., 2005a; Clara et al., 2005b; Kimura et al., 2005; Quintana et 
al., 2005; Bernhard et al., 2006; González et al., 2006; Kim et al., 2007; 
Kimura et al., 2007; Radjenovic et al., 2007; Snyder et al., 2007; Pérez 
and Barceló 2008; Barceló et al., 2009; Radjenovic et al., 2009; Xue et 
al., 2010; Sahar et al., 2011a; Sui et al., 2011; Lipp et al., 2012; Malpei et 
al., 2012; Trinh et al., 2012b; Cartagena et al., 2013; Oosterhuis et al., 
2013; Phan et al., 2015; Qi et al., 2015; Arriaga et al., 2016; Trinh et al., 
2016b; Arola et al., 2017; Park et al., 2017; Tran and Gin 2017) 
Metformin 94-99 (Trinh et al., 2012b; Oosterhuis et al., 2013; Kim et al., 2014) 
Carbamazepine <0-96 (Kreuzinger et al., 2004; Clara et al., 2005a; Clara et al., 2005b; Joss et 
al., 2005; Bernhard et al., 2006; Kim et al., 2007; Radjenovic et al., 2007; 
Snyder et al., 2007; Barceló et al., 2009; Radjenovic et al., 2009; Xue et 
al., 2010; Sui et al., 2011; Dialynas and Diamadopoulos 2012; Dolar et 
al., 2012; Lipp et al., 2012; Malpei et al., 2012; Trinh et al., 2012b; 
Cartagena et al., 2013; Oosterhuis et al., 2013; Kim et al., 2014; Komesli 
et al., 2015; Phan et al., 2015; Qi et al., 2015; Arriaga et al., 2016; Arola 
et al., 2017; Park et al., 2017; Tran and Gin 2017) 
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Lamotrigine 0-84 (Bollmann et al., 2016) 
Triclosan 41-96 (Kim et al., 2007; Snyder et al., 2007; Kantiani et al., 2008; Coleman et 
al., 2009; Trinh et al., 2012b; Cartagena et al., 2013; Tran et al., 2016; 
Trinh et al., 2016b) 
Industrial Chemicals 
2,6-Ditert-butyl-4-
methylphenol(BHT) 
N.A.  
Tris(2-chloroethyl) 
phosphate (TCEP) 
<0-37 (Bernhard et al., 2006; Kim et al., 2007) 
Tetrabromobisphenol A 62-90 (Potvin et al., 2012) 
Hexabromocyclododecane 
(HBCD) 
N.A.  
Benzotriazole (BTA) 15-74 (Weiss and Reemtsma 2008; Sahar et al., 2011b; Qi et al., 2015; Arriaga 
et al., 2016) 
N-Nitrosodimethylamine 
(dimethyl-nitrosamine)* 
(NDMA) 
70-94 (Gerrity et al., 2015; Mamo et al., 2016) 
Perfluorobutanoic acid 
(PFBA) 
11 (Pan et al., 2016) 
Perfluoropentanoic acid 
(PFPeA) 
<0 (Pan et al., 2016) 
Perfluorohexanoic acid 
(PFHxA) 
<0 (Pan et al., 2016) 
Estrogens 
Estrone (E1) 58-100 (Joss et al., 2004; Clara et al., 2005a; Joss et al., 2005; Zuehlke et al., 
2006; Coleman et al., 2009; Le-Minh et al., 2010; Xue et al., 2010; Cases 
et al., 2011; Wu et al., 2011a; Trinh et al., 2012a; Trinh et al., 2012b; He 
et al., 2013; Phan et al., 2015; Trinh et al., 2016b) 
17β-Estradiol (E2) 39-100 (Joss et al., 2004; Clara et al., 2005a; Zuehlke et al., 2006; Lee et al., 
2008; Le-Minh et al., 2010; Xue et al., 2010; Wu et al., 2011a; Dialynas 
and Diamadopoulos 2012; Trinh et al., 2012a; Trinh et al., 2012b; He et 
al., 2013; Trinh et al., 2016b) 
17α-Ethynylestradiol 
(EE2) 
20-100 
 
(Clara et al., 2004; Joss et al., 2004; Kreuzinger et al., 2004; Clara et al., 
2005a; Zuehlke et al., 2006; Le-Minh et al., 2010; Xue et al., 2010; Wu et 
al., 2011b; Dialynas and Diamadopoulos 2012; He et al., 2013; Trinh et 
al., 2016b)  
Personal care products 
2-Ethylhexyl 
ethoxycinnamate (EHMC) 
N.A.  
Neonicotinoids 
Imidacloprid N.A.  
Thiacloprid N.A.  
Thiamethoxam N.A.  
Clothianidin N.A.  
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Acetamiprid N.A.  
Pesticides 
Methiocarb N.A.  
Oxadiazon N.A.  
Triallate N.A.  
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4.4 Constructed Wetlands  
Constructed wetlands (CWs) are treatment systems that use natural processes involving wetland 
vegetation, soils, and their associated microbial assemblages. As nature-based solutions, CWs have 
the potential to address societal and economical challenges related to safe water reuse. If well 
designed and maintained, CWs may provide effluents suitable for water reuse (Rousseau et al., 
2008).  
CWs are mainly used to efficiently remove organic matter, suspended solids, nutrients, and some 
metals from wastewater, and in recent years, CWs have been used also to remove organic pollutants, 
such as pesticides (Matamoros and Salvadó 2012), hydrocarbons (Guittonny-Philippe et al., 2015) 
and a few CEC (Gorito et al., 2017). Currently, CWs are recognized as a reliable wastewater 
treatment technology, representing a suitable solution for the treatment of many types of 
wastewaters, such as municipal or domestic wastewaters, storm water, agricultural wastewaters and 
industrial wastewaters (such as petrochemicals, pulp and paper, food wastes and mining industries) 
(Vymazal 2011a). Furthermore, due to their simple set-up and low maintenance, CWs can be used in 
rural areas, where the treated water can be reused in agriculture. 
CWs are applied as a secondary treatment of municipal wastewater in relatively small communities, 
i.e. up to 1000 population equivalent (PE), but can also be used for the treatment of wastewater from 
greater areas covering 2000 PE (or more) (Vymazal 2011b). A limitation of the use of CWs for large, 
urbanized areas is associated with the higher area demand for these systems in comparison to the 
techniques based on activated sludge. Various examples exist on the removal of CEC in secondary 
treatments (Table 5 and Table SM4), and only a few applications of CWs for removing CEC during 
the polishing of wastewater effluent as a tertiary treatment are reported (Dordio et al., 2007; Imfeld 
et al., 2009; Bui and Choi 2010; Bhatia and Goyal 2014; Garcia-Rodríguez et al., 2014).  
The removal efficiencies of the tested CEC are seasonally variable, with higher removal percentages 
in summer compared to winter (Garcia-Rodríguez et al., 2014; Li et al., 2014b). Furthermore, 
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different designs exist, such as surface flow CWs (SF CWs), and sub-surface flow CWs with 
horizontal (HF) and vertical (VF) flows (Vymazal 2011b). Higher removal rates were found in 
systems with sub-surface flow (horizontal) CWs to surface flow CWs (Imfeld et al., 2009; Berglund 
et al., 2014; Bhatia and Goyal 2014; Li et al., 2014b; Díaz‐Cruz and Barceló 2015). Other important 
parameters are water depth, HRT, vegetation type, temperature (seasonality), and substrate (CWs 
filling) type (Verlicchi and Zambello 2014; Zhang et al., 2014). 
In the literature, various CWs applications for CEC removal are described, and details for the 
selected compounds are given in Table 5 and Table SM4, and described below. Current literature 
focuses on measuring influent and effluent concentrations of CEC to evaluate the overall removal 
performance, rather than detailed studies on the actual fate of target compounds or their removal 
pathways. CWs have shown the potential to remove CEC from urban/domestic wastewaters, 
including diclofenac, metformin, carbamazepine, triclosan, trimethoprim, clarithromycin, 
erythromycin, sulfamethoxazole, estrone, 17β-estradiol, 17α-ethynylestradiol, and benzotriazole (see 
Table 5 and Table SM4 for details and percent removal efficiency). Diclofenac is the most studied 
CEC, described in almost 70% of the published studies on CEC removal in CWs (see Table 5). Other 
well-studied compounds are the pharmaceuticals carbamazepine and triclosan and the antibiotics 
trimethoprim and sulfamethoxazole.  
In detail, many of the studied compounds showed removal up to 100%. Nevertheless, the removal 
percentage is dependent on the CWs operational parameters, e.g. surface flow or subsurface flow 
(either horizontal or vertical) as can be seen in Table SM4. For instance, benzotriazole and 
trimethoprim were more effectively removed in vertical subsurface flow CW that in a surface flow 
CW. Especially the vertical sub-surface flow CWs are known to promote biodegradation. The water 
flow affects the redox conditions which in turn affects removal mechanisms, resulting e.g. in a better 
removal of metformin under oxic conditions in a sub-surface flow CW. Other factors, such as plants 
presence, plants species and temperature (seasonal) can also determine compounds removal. For 
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instance, the removal of E1, E2 and EE2 increased in summer compared to winter. On the other 
hand, erythromycin and clarithromycin removals were favoured in the presence of plants, 
particularly in the presence of Iris tectorum. Triclosan removal was also favoured by a higher 
temperature and by the presence of the plant Phragmites australis. Details on these studies are given 
in Table SM4. 
Despite the high removal rates observed for the above-mentioned compounds, at least three 
compounds showed limited removal in CWs, due to their more recalcitrant nature. Diclofenac, 
carbamazepine and sulfamethoxazole were poorly removed in most studies, with only 1 or 2 studies 
showing higher removal. For example, a reported removal of carbamazepine in sub-surface 
horizontal flow CWs higher than 88% is remarkable (Garcia-Rodríguez et al., 2014), as this 
pharmaceutical is known to be poorly biodegradable. The mechanism of carbamazepine removal has 
not been fully elucidated, but Garcia-Rodríguez et al., (2014) describe a relation between the 
removal efficiency and residence time in the CW. The few parameters that are known to have a 
positive effect, e.g. vertical subsurface flow, higher temperature and plant presence, only slightly 
improved the removal of these three compounds. As a result, these 3 compounds are considered 
moderately removed by CWs indicating that CWs treatment should be combined with other 
wastewater treatments for an efficient removal of these compounds for wastewaters. 
Other CEC, such as the antibiotics enrofloxacin (veterinary application) and ciprofloxacin, have not 
been mentioned in studies of urban/domestic wastewater CWs treatment. However, studies with e.g. 
livestock wastewater show the potential of CWs for secondary treatment (Hsieh et al., 2015; Almeida 
et al., 2017).So far, removal of the majority of industrial chemicals (see Table 5), neonicotinoids, and 
selected pesticides in a CW has not been described. Of the neonicotinoids, 100% removal of 
imidacloprid in a CW has been reported, although spiked water was used instead of real wastewater. 
These results indicate that more research on CWs applicability to remove these compounds from 
wastewater is needed.  
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To conclude, CWs can be used for secondary treatment of wastewater containing selected CEC. 
There are several factors important when using a CW, such as the available area, CW design and 
operational conditions and the impact of seasonal conditions. Just like CAS systems, current CWs 
are not able to entirely eliminate CEC from wastewater. The efficiency of the processes occurring in 
CWs depends primarily on the operation mode, design, type of substrate and the presence and type of 
plants. The effectiveness of the processes in the CWs can be increased by the use of hybrid systems, 
which combine CWs of different design connected in series (Vymazal 2011b; Garcia-Rodríguez et 
al., 2014; Verlicchi and Zambello 2014; Zhang et al., 2014; Díaz‐Cruz and Barceló 2015). 
Combinations of CWs with other processes are also feasible, e.g. processes induced by sunlight 
(with/without photocatalysts) as the final stage of purification (Mahabali and Spanoghe 2013; Felis 
et al., 2016; He et al., 2016). 
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Table 5. Range of the removal efficiencies of selected CEC in different types of CWsa 
Category Removal 
efficiency (%) 
References 
Antibiotics   
Trimethoprim 0-100 (Hijosa-Valsero et al., 2011a; Dan et al., 2013; Du et al., 2014; Chen et 
al., 2016; Ávila et al., 2017)  
Erythromycin 0-92 (Hijosa-Valsero et al., 2011a; Ávila et al., 2014b; Du et al., 2014; Chen et 
al., 2016)  
Clarithromycin 11-98 (Hijosa-Valsero et al., 2011a; Chen et al., 2016; Vymazal et al., 2017) 
Azithromycin N.A.  
Sulfamethoxazole 0-75 (Hijosa-Valsero et al., 2011a; Dan et al., 2013; Du et al., 2014; Chen et 
al., 2016; Auvinen et al., 2017; Ávila et al., 2017) 
Enrofloxacin N.A.  
Ciprofloxacin N.A.  
Other pharmaceuticals/antimicrobials 
Diclofenac  0-75 (Matamoros and Bayona 2006; Matamoros et al., 2007; Matamoros et al., 
2009; Hijosa-Valsero et al., 2010b; Hijosa-Valsero et al., 2011a; Hijosa-
Valsero et al., 2011b; Hijosa-Valsero et al., 2012; Reyes-Contreras et al., 
2012; Ávila et al., 2013; Ávila et al., 2014a; Ávila et al., 2014b; Carranza-
Diaz et al., 2014; Du et al., 2014; Hijosa-Valsero et al., 2016; Auvinen et 
al., 2017; Vymazal et al., 2017) 
Metformin 99±1 (Auvinen et al., 2017) 
Carbamazepine 0-50 (Hijosa-Valsero et al., 2010b; Hijosa-Valsero et al., 2011a; Hijosa-
Valsero et al., 2011b; Reyes-Contreras et al., 2011; Camacho-Muñoz et 
al., 2012; Hijosa-Valsero et al., 2012; Reyes-Contreras et al., 2012; 
Carranza-Diaz et al., 2014; Du et al., 2014; Hijosa-Valsero et al., 2016; 
Auvinen et al., 2017; Ávila et al., 2017) 
Lamotrigine N.A.  
Triclosan 2-88 (Matamoros et al., 2007; Reyes-Contreras et al., 2011; Ávila et al., 2014b; 
Carranza-Diaz et al., 2014; Vymazal et al., 2017) 
Industrial Chemicals 
2,6-Ditert-butyl-4-
methylphenol(BHT) 
N.A.  
Tris(2-chloroethyl) 
phosphate (TCEP) 
N.A.  
Tetrabromobisphenol A N.A.  
Hexabromocyclododecane 
(HBCD) 
N.A.  
Benzotriazole (BTA) 8-100 (Matamoros et al., 2010) 
N-Nitrosodimethylamine 
(dimethyl-nitrosamine)* 
(NDMA) 
N.A.  
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Perfluorobutanoic acid 
(PFBA) 
N.A.  
Perfluoropentanoic acid 
(PFPeA) 
N.A.  
Perfluorohexanoic acid 
(PFHxA) 
N.A.  
Estrogens 
Estrone (E1) 0-90 (Peterson and Lanning 2009; Qiang et al., 2013; Vymazal and Březinová 
2015; Dai et al., 2016) 
17β-Estradiol (E2) 0-100 (Peterson and Lanning 2009; Qiang et al., 2013; Vymazal and Březinová 
2015; Dai et al., 2016) 
17α-Ethynylestradiol 
(EE2) 
8-100 (Kumar et al., 2011; Qiang et al., 2013; Ávila et al., 2014b; Vymazal and 
Březinová 2015)  
Personal care products 
2-Ethylhexyl  
ethoxycinnamate (EHMC) 
N.A.  
Neonicotinoids 
Imidacloprid N.A.  
Thiacloprid N.A.  
Thiamethoxam N.A.  
Clothianidin N.A.  
Acetamiprid N.A.  
Pesticides 
Methiocarb N.A.  
Oxadiazon N.A.  
Triallate N.A.  
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4.5 Moving bed biofilm reactor  
Moving bed biofilm reactors (MBBRs) seem to be a promising alternative for the elimination of 
micropollutants. However, only few studies reported the application of the MBBR technology for 
CEC removal (Escola Casas et al., 2015a; Mazioti et al., 2015), and the studies based on real 
wastewater and full- to pilot-scale systems are missing. Therefore, lab-scale studies evaluating 
MBBR process as a secondary treatment for CEC removal from wastewater, which were based either 
on synthetic wastewater or hospital wastewater, are also considered. The contribution of biofilm 
communities (Torresi et al., 2017), its add-in value inside a hybrid MBBR system (Falas et al., 2013; 
Escola Casas et al., 2015b) or its contribution as a polishing treatment (Escola Casas et al., 2015b; 
Tang et al., 2017; Torresi et al., 2017) for CEC removal were also investigated. Details of these 
studies can be found in Table 6, Table SM5 and Table SM6. 
The performance of an MBBR system for the removal of pharmaceuticals from pre-treated hospital 
raw wastewater was evaluated by Escola Casas et al., (2015a). The system consisted of three 
identical reactors in series, with biomass concentrations of 3.1, 1.4, and 0.5 g/L respectively. The 
results showed that both high organic load (co-metabolism in the first reactor) and low organic load 
(more effective biofilm in the third reactor) acted for the overall removal of the pharmaceuticals. 
However, the comparison of the kinetic coefficient kbiol between the three reactors showed that four 
pharmaceuticals had higher kbiol in the third reactor (carbamazepine, clarithromycin, ciprofloxacin, 
and erythromycin) while diclofenac, sulfamethoxazole, and trimethoprim showed higher kbiol in the 
second one. Escola Casas et al., (2015a) paved the way for the development of MBBR reactors with 
higher concentration of efficient biomass for the removal of recalcitrant pharmaceuticals. 
Mazioti et al., (2015) compared degradation of benzotriazole in CAS with a sludge return (HRT 26.4 
± 2.4 h), MBBR at low organic load rate (OLR) (0.25 ± 0.16 kg m-3 day-1, HRT 10.8 ± 1.2 h), and 
MBBR at high OLR (0.6 ± 0.4 kg m-3 d-1, HRT 26.4 ± 2.4 h). Results showed similar removal 
efficiencies for the CAS system and MBBR at low OLR and worse results at high OLR. Specific 
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removal (µg g-1 day-1) doubled between the first reactor at high OLR and the first reactor at low OLR 
(11.3 ± 1.6 µg g-1 day-1) or the second bioreactor at high OLR (5.7 ± 1.9 µg g-1 day-1). As co-
metabolism (COD and NH4) showed nearly no differences for benzotriazole removal, this difference 
should be in relation with biomass specification even no bacterial communities’ analysis was 
performed.  
In general, the efficiency of biological process is linked with physicochemical characteristics of the 
compound (kbiol, kd) and process parameters (temperature, HRT, SRT, pH, redox conditions). As 
MBBR is a biological process, the main removal mechanism is biodegradation which is quantified 
by the kbiol constant (L h-1g-1). SRT, OLR, and nitrification rate are higher in MBBR and have a 
positive impact on CEC removal (Oulton et al., 2010).  
These studies showed that both co-metabolism and balanced bacterial diversity could enhance CEC 
removal to some extent. The application of MBBR is not restricted to secondary biological treatment 
but may also have a successful future in polishing treatment. A comprehensive bibliographic review 
has been done on use of bacterial supports for the CEC removal and is summarized in Table 6, Table 
SM5 and Table SM6.  
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Table 6. Range of the removal efficiencies of the selected CEC in MBBRs  
Category Removal 
efficiency (%) 
References 
Antibiotics   
Trimethoprim 2-96  (Escola Casas et al., 2015a; Escola Casas et al., 2015b; Tang et al., 2017) 
Erythromycin 16-35  (Escola Casas et al., 2015a; Escola Casas et al., 2015b) 
Clarithromycin 47-61  (Escola Casas et al., 2015a; Escola Casas et al., 2015b) 
Azithromycin BDL-34  (Escola Casas et al., 2015a; Escola Casas et al., 2015b) 
Sulfamethoxazole (-28)-28  (Escola Casas et al., 2015a; Escola Casas et al., 2015b; Tang et al., 2017) 
Enrofloxacin (-36)-21  (Escola Casas et al., 2015a; Escola Casas et al., 2015b; Tang et al., 2017) 
Ciprofloxacin 2-96  (Escola Casas et al., 2015a; Escola Casas et al., 2015b; Tang et al., 2017) 
Other pharmaceuticals/antimicrobials 
Diclofenac  25-100 
 
(Falas et al., 2013; Zupanc et al., 2013; Luo et al., 2014; Luo et al., 2015; 
Tang et al., 2017) 
Metformin N.A.  
Carbamazepine 0-75 (Falas et al., 2013; Zupanc et al., 2013; Luo et al., 2014; Escola Casas et al., 2015a; Escola Casas et al., 2015b; Luo et al., 2015; Tang et al., 2017) 
Lamotrigine N.A.  
Triclosan 80-92 (Luo et al., 2014; Luo et al., 2015) 
Industrial Chemicals 
2,6-Ditert-butyl-4-
methylphenol(BHT) 
N.A.  
Tris(2-chloroethyl) 
phosphate (TCEP) 
N.A.  
Tetrabromobisphenol A N.A.  
Hexabromocyclododecane 
(HBCD) 
N.A.  
Benzotriazole (BTA) 43-76  (Mazioti et al., 2015) 
N-Nitrosodimethylamine 
(dimethyl-nitrosamine)* 
(NDMA) 
N.A.  
Perfluorobutanoic acid 
(PFBA) 
N.A.  
Perfluoropentanoic acid 
(PFPeA) 
N.A.  
Perfluorohexanoic acid 
(PFHxA) 
N.A.  
Estrogens 
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Estrone (E1) 65-95 (Luo et al., 2014; Luo et al., 2015; Amin et al., 2018) 
17β-Estradiol (E2) 95-100 (Luo et al., 2014; Luo et al., 2015; Amin et al., 2018) 
17α-Ethynylestradiol 
(EE2) 
90-98 (Luo et al., 2014; Luo et al., 2015; Amin et al., 2018) 
Personal care products 
2-Ethylhexyl  
ethoxycinnamate (EHMC) 
N.A.  
Neonicotinoids 
Imidacloprid N.A.  
Thiacloprid N.A.  
Thiamethoxam N.A.  
Clothianidin N.A.  
Acetamiprid N.A.  
Pesticides 
Methiocarb N.A.  
Oxadiazon N.A.  
Triallate N.A.  
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5. Effect of secondary treatments on microbial CEC fate  
Although antibiotic resistance and antibiotic residues may occur together in the environment, 
antibiotic resistance is not a direct consequence of chemical environmental contamination (Michael 
et al., 2013; Varela et al., 2014). Instead, ARB&ARGs are emitted from human and animal sources, 
also irrespective of the occurrence of antibiotics, and have the capacity to survive or self-replicate in 
the environment. These arguments place ARB&ARGs among the broad group of CEC (Pruden et al. 
2006; Berendonk et al. 2015). Given the current state of the art and the knowledge gaps concerning 
the effect of secondary treatment on antibiotic resistance, this section discusses why urban 
wastewater treatment plants are reservoirs of ARB&ARGs (Berendonk et al., 2015; Manaia et al., 
2016) and why control strategies are so difficult to devise and implement. WWTPs collect most of 
the pharmaceutical compounds, including antibiotic residues which are increasingly used in the 
modern medicine and poorly metabolized in the human body (Segura et al., 2009; Segura et al., 
2011; Michael et al., 2013). Unfortunately, antibiotic residues do not come alone. They are mingled 
with a wide diversity of human commensal and pathogenic bacteria, many of which harbour ARGs, 
acquired in a bacterial struggle for survival, while being able to persist and spread in the environment 
(Manaia et al., 2016). ARGs may be located on chromosomes or on plasmids, making the horizontal 
transfer of genes among neighbouring cells a possibility. Resistance genes encode different types of 
defence mechanisms that alone or in combination with other genetic determinants, may increase the 
capacity of bacteria to survive adverse conditions (Yomoda et. al., 2003; Kim et al., 2014). 
Wastewater secondary treatment systems have the potential to offer ideal conditions for bacteria to 
spread their genes, in particular ARGs, and hence they can be associated with antibiotic resistance 
dissemination (Rizzo et al., 2013, Bouki et al., 2013). The wealth of nutrients and cell-to-cell 
interactions, aided by the presence of antibiotic residues and, eventually, other selectors, are believed 
to enhance the chances of survival or even proliferation of ARB (Berendonk et al., 2015; Bengtsson-
Pvaalme and Larsson, 2016). 
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The need of elucidating the potential impact of WWTPs on the dissemination of ARB&ARGs has 
been urged by the accumulation of evidences that the use of reclaimed water used for irrigation may 
contribute to the transmission of ARB and other water-borne bacteria through different 
environmental compartments. Potential microbiological risks associated with water reuse in 
irrigation cannot be neglected (Pachepsky et al., 2012; Al-Jassim et al., 2015) and this review aimed 
at assessing what is known regarding ARB&ARGs removal by full-scale WWTP systems operated 
with different secondary treatment technologies. 
Recent studies on this topic that share common overall experimental approaches are reviewed in this 
paper (Table 7). Given the relevance of the disinfection effects on the fate of ARB&ARGs and the 
difficulty in identifying the role of the secondary treatment units from the available literature, some 
data reported in the Table 7 includes also the disinfection step. A few aspects that can explain the 
variation in the data presented are worth mentioning (Table 7). First, diverse methodologies are used 
for the screening of genes in total DNA extracts or cultivation methods, a disparity that is enhanced 
by a wide array of variables that may influence the results. For culture-based methods, the results 
will be strongly influenced by the choice of the culture medium or the imposition of some selective 
pressures. For culture-independent methods, the DNA extraction process, the primers used for PCR-
based gene search or the technique and conditions used for metagenome analyses as well as the 
database and analytical pipeline used, are enough to influence the results. Second, there is a lack of 
information on the external conditions during the full-scale conventional treatment, not only those 
referring to operational settings, but also climate conditions and numerous quality parameters. Third, 
the sampling scheme is different among studies and microbial targets analysed. In spite of such 
potential confounding variables, we can conclude that full-scale CAS plants have a limited capacity 
to reduce antibiotic resistance to negligible levels. In the next section, we will discuss the impact of 
the WWTP processes on: i) culturable total and ARB, ii) multi-drug resistance phenotypes, iii) ARGs 
and iv) metagenomics insights of antibiotic resistance. 
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5.1 Fate of culturable antibiotic-resistant bacteria 
The reduction in the number of total and ARB has been examined in various studies, in the influent 
and secondary effluent of WWTP as a method to infer the efficiency of wastewater treatment to 
remove antibiotic resistance. This is achieved with the use of bacterial cultivation and enumeration 
methods, in selective media supplemented or not with antibiotics. This approach can be used to 
assess the effectiveness of the WWTP process as for instance is reported by Zanotto et al., (2016). 
These authors showed that a CAS process could reduce the ampicillin and chloramphenicol-resistant 
coliforms and Escherichia coli by 2 log units. However, the biological treatment did not reduce the 
percentage of ARB among total bacteria (maintenance of prevalence values). It has been shown in 
this study that the disinfection step with peracetic acid was important in the reduction of ampicillin-
resistant E. coli, to densities below 10 CFU/100 mL. In contrast, in another study by Mao et al., 
(2015), it was observed that bacteria harbouring ARGs persisted throughout all treatment stages, 
surviving better after chlorination than total bacteria. Su et al., (2014) observed that even though total 
culturable bacteria and E. coli decreased after the WWTP process (2.3-3.3 log unit reduction), the 
quinolone- and ampicillin-resistant bacteria prevalence was not significantly reduced (from 55% in 
the influent to 61% in the effluent). Sidrach-Cardona and Bécares (2013) have shown removal of 90-
99% ARB from urban wastewater in CWs. This study showed that CWs design can affect the system 
performance, with planted sub-surface flow CWs being more efficient for this type of biological 
pollutants. Processes such as ﬁltration, adsorption, aggregation, and metabolic activity of bioﬁlm 
microorganisms and macrophytes are responsible for bacterial removal in CWs (García et al., 2008; 
Wu et al., 2016). It is not clear if plants have a direct effect on bacterial removal, as the presence of 
plants can indirectly increase removal through conductivity modiﬁcation, gas transport and 
enhancement of bioﬁlm development, adsorption, aggregation and ﬁltration (García et al., 2008).  
The above suggest that the tertiary treatment is important in the removal of total bacteria, but it is not 
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always effective in removing ARB, thus leading to their persistence in the disinfected effluent, with 
possible contamination of the receiving environment.  
5.2 Multi-drug resistance phenotypes 
Multidrug-resistant (MDR) bacteria have been defined as those that have acquired non-susceptibility 
to at least one agent belonging to three or more antimicrobial categories (ECDC/EMEA, 2009). It 
was shown in several studies that MDR phenotypes occur in final effluent samples, evidencing that, 
as for many other bacteria, also MDR bacteria can survive treatment. Among the studies included in 
this review, there were MDR-positive isolates to the following antibiotics, among others: 
ciprofloxacin, trimethoprim and sulfamethoxazole/trimethoprim (Al-Jassim et al., 2015; Zhang et al., 
2015b; Lopes et al., 2016; Osinska et al., 2017). The same pattern of MDR E. coli isolates was found 
by Osinska et al., (2017) and Lopes et al., (2016) in the wastewater effluent analysed, showing 
prevalence values above 30%. The prevalence of MDR E. coli isolates reported by Blaak et al., 
(2015) was lower, but still represented 20% of the total number of isolates in effluent wastewater. 
Kotlarska et al., (2015) also reported MDR E. coli in wastewater effluent in two WWTPs (2.4 (0.1–
6.1) × 105 and 2.1 (0.8–3.1) × 105 CFUs per 100 mL). Zhang et al., (2015b) selected 200 
heterotrophic bacteria from three WWTPs (influent and effluent), seasonally. They reported MDR 
isolates ranging from 5 to 64%.  From these studies it is not possible to draw a general overview or 
define a trend. Apparently, more studies targeting MDR phenotype prevalence in wastewater 
effluents may be needed, preferentially targeting other bacteria besides E. coli. Another limitation is 
the use of ambiguous and not always correct definitions of MDR that are reported in the scientific 
literature, which may launch several misinterpretations of the meaning and impact of MDR in urban 
wastewater effluents.  
 
5.3 Fate of antibiotic resistance genes  
51 
 
The quantitative PCR (qPCR) of specific ARGs has brought a new breath to the assessment of 
wastewater treatment efficiency regarding the removal of antibiotic resistance genes. Rafraf et al., 
(2016) observed the presence of various ARGs including the integrase gene except blaCTX-M in the 
influent and effluent samples of five WWTPs employing biological processes (CAS, CAS-UV, 
aerated lagoon). The quantification of the examined ARGs showed that there was no difference in 
their abundance before and after the treatment which is also in agreement with Xu et al., (2015), once 
more highlighting the tolerance of ARB and their associated genes to the applied WWTP treatments. 
This is supported by the study of Al-Jassim et al., (2015), where it was observed that tetO, tetQ, 
tetW, tetH, tetZ were also present in the post-CAS chlorinated treated effluent. Wen et al., (2016) 
observed that the biological treatment had an important role in the removal of ARGs followed by UV 
disinfection, although high concentrations of ARGs were found in the treated effluents. Mao et al., 
(2015) observed a 90% reduction in ARGs from influent to effluent in CAS. However, even after 
chlorination, the remaining ARGs were still in high levels, and tetA, tetB, tetE, tetG, tetH, tetS, tetT, 
tetX, sul1, sul2, qnrB and ermC were discharged through the dewatered sludge and plant effluent at 
higher rates than influent values. The latter finding is supported by the study of Alexander et al., 
(2015), where the abundance of various ARGs increased after conventional WWTP process, 
resulting in the surface water receiving a high abundance of various ARGs. Laht et al., (2014) 
demonstrated a decrease by several orders of magnitude in raw 16S rRNA and ARGs gene copy 
numbers (tetC, tetM, sul1, sul2, blaCTX-M-32, blaSHV-34, blaOXA-58) in the effluent compared to the 
influent, in three CAS WWTPs. In the same study, when the ARGs abundance was normalised per 
16S rRNA, it was shown that when relative abundances were compared, there was a statistically 
significant difference (p<0.01) between influent and effluent samples, in only four cases, among the 
three examined WWTPs. This is a finding which is in agreement with a study on CAS by Bengtsson-
Palme et al., (2016). CWs have shown the removal potential of both antibiotics and antibiotic 
resistance genes in a few studies as reviewed by Sharma et al., (2016), which can ultimately affect 
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the amount of antibiotic resistance bacteria in CWs effluents. In these studies, both domestic/urban 
and livestock wastewaters have been tested. For domestic/urban wastewaters, CWs can remove 
significant amounts of antibiotic resistance genes (45-99 %) belonging, for instance, to tetracycline, 
fluoroquinolone and sulfonamides antibiotic classes (Liu et al., 2013; Nolvak et al., 2013; Chen et 
al., 2015; Huang et al., 2015; Chen et al., 2016; Huang et al., 2017).  
However, most of the papers present the removal results after a combined treatment process 
consisting of biological treatment and disinfection, and do not provide data on the actual biological 
process removal effectiveness. Therefore, it is not possible to clearly distinguish the effects of the 
biological treatment on the ARGs. 
5.4 Antibiotic resistance through the metagenomics lens 
Metagenomics approaches applied to resistome and bacterial community analyses have come into the 
spotlight in the last few years, due to the rapid technological development and reduction in the 
potential cost of such equipment. As a result, more studies are arising which perform in-depth 
analyses of the resistome and wastewater bacterial communities before and after WWTP processes. 
Christgen et al., (2015) explored five wastewater treatment options, such as: i) a completely mixed 
aerobic reactor (AER1), ii) an up-flow anaerobic sludge blanket reactor (UASB), iii) an anaerobic 
hybrid reactor (AHR), and iv-v) two anaerobic−aerobic sequence (AAS) bioreactors following 
UASB and AHR reactors, respectively. The analysis of the relative abundance of ARGs (abundance 
of ARG sequences reads the total reads number) showed that the AAS and aerobic treatment were 
able to remove a higher number of ARGs, among the total number of reads, such as 
aminoglycosides, tetracycline and β-lactam resistance genes compared to UASB and AHR, 
indicating the higher capacity of the combined aerobic system for ARGs removal, compared to the 
anaerobic processes. However, the relative abundance of sulfonamide and chloramphenicol 
resistance genes was unaffected by AAS. In another study (Yang et al., 2014), identified 271 
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subtypes of ARGs belonging to 18 classes. The highest abundance of ARGs among the total number 
of reads was observed in the influent of the WWTP, while 78 ARGs persisted throughout the 
treatment, among the total number of ARGs reads. Finally, significant statistical correlation between 
specific bacterial genera which include opportunistic pathogens, and ARGs distribution, was 
observed, suggesting their contribution as carriers of ARGs. 
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Table 7. Most recent studies examining the fate of ARB&ARGs in full-scale WWTPs operated with different processes and technologies  
Country  
 & Reference 
 
Process/ 
Technology 
Aim(s) Biological target/experimental approach/chemical analyses Study findings 
Poland 
 
(Osinska et al., 2017) 
 
 
 
Conventional 
Activated Sludge 
(CAS) 
Compare antibiotic resistance and 
virulence before and after CAS 
treatment 
  
 
Isolates: E. coli resistant to amoxicillin, tetracycline 
or ciprofloxacin 
Approach: Isolation on mFC, genotyping (ERIC-
PCR), antibiograms (3 antibiotics), gene detection 
(PCR) 
Reduction of the counts of beta-lactam, tetracycline and fluoroquinolone-resistant E. coli 
after treatment 
Multi-drug resistance observed in 38% of the 317 isolates analysed 
Most common antibiotic resistance genes: blaTEM and blaOXA and tetA, tetB and tetK  
Most common virulence genes: bfpA, ST and eae  
Brazil 
 
(Conte et al., 2017) 
 
 
 
 
CAS Survey of beta-lactam and quinolone resistant bacteria after 
CAS treatment 
Isolates: E. coli, Klebsiella pneumoniae and 
K.  oxytoca resistant to quinolones  
Approach: Isolation on MacConkey, genotyping 
(ERIC-PCR), antibiograms (9 antibiotics) and MICs 
(8 antibiotics), gene detection (PCR) 
Antibiotics: Ciprofloxacin 
Cephalosporin and quinolone resistance found in 34.4% of E. coli and 27.3% of K. 
pneumoniae 
Carbapenem resistance found in 5.4% of K. pneumoniae and K. oxytoca 
ESBL-producing isolates found in raw and treated water samples  
Ciprofloxacin residues were absent only in upstream river water 
China 
 
(Ben et al., 2017) 
1) Anaerobic/anoxi
c/oxic (A2/O)-
Membrane 
Bioreactor 
(MBR) 
2) Oxidation ditch-
coagulation/sedi
mentation 
3) Anoxic/oxic 
(A/O)-MBR 
4) A2/O-
ultrafiltration 
(UF) 
5) A/O-biofilter-UF 
6) A/O 
7) Oxidation ditch-
Rotary fibre disk 
filtration (RFDF) 
8) A2/O- RFDF 
9) A2/O/coagulation
/sedimentation-
RFDF 
10) A2/O-
coagulation/sedi
mentation-RFDF 
Assess possible correlations 
between antibiotic resistance and 
sulfonamides (SA) or 
tetracyclines (TC) in ten WWTPs 
with different treatment types, all 
of them including disinfection  
 
Isolates: Heterotrophic bacteria, resistant to 
tetracycline and sulfamethoxazole 
Total community DNA 
Approach: Isolation on LA, gene quantification 
(qPCR) 
Antibiotics: Sulfonamides, tetracyclines 
 
ARGs detected after treatment in all 10 WWTP, with sulfonamide resistance being the most 
abundant type of resistance 
Total SA and TC concentrations were not significantly correlated with the corresponding 
ARB&ARGs 
Positive correlation between ARGs and intI1 
The statistically significant decrease of ARGs abundance evidences the importance of 
disinfection for antibiotic resistance control 
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Country  
 & Reference 
 
Process/ 
Technology 
Aim(s) Biological target/experimental approach/chemical analyses Study findings 
 
Brazil 
 
(Lopes et al., 2016) 
Biological aerated 
filter system 
(RALF) 
Assess the occurrence of 
thermotolerant coliforms and E. 
coli resistant to various 
antimicrobials in an WWTP 
Isolates: thermotolerant coliforms, antibiotic-resistant 
E. coli   
Approach: Isolation on non-selective medium and 
antimicrobial susceptibility testing 
Antibiotics: norfloxacin, ciprofloxacin, cephalothin, 
gentamycin, streptomycin, imipenem, cefaclor, 
ampicillin, cefoxitin, tetracycline, amoxicillin and 
chloramphenicol 
 
There were E. coli isolates resistant to cephalothin, streptomycin, tetracycline and 
amoxicillin; 
A higher prevalence of resistant isolates was observed in the WWTP effluent and 
downstream of the WWTP. 
Tunisia 
 
(Rafraf et al., 2016) 
 
 
1) CAS 
2) CAS-UV 
3) Aerated Lagoons 
Assess the efficiency of 
wastewater treatment on 
antibiotic resistance removal in 
five WWTP (four with CAS one 
of which has CAS-UV, and one 
with aerated lagoons as the 
secondary process) 
Total community DNA  
Approach: gene quantification (qPCR) 
 
The gene intI1 and all ARGs, except blaCTX-M, were detected in influent and effluent samples 
in all WWTPs tested with relative ARGs abundance being similar before and after treatment 
The abundance of blaCTX-M, blaTEM, and qnrS genes was higher in the effluent of the WWTP 
that receives untreated hospital effluents 
China 
 
(Sun et al., 2016) 
 
 
 
A2/O -MBR 
Assess the overall distribution of 
ARGs by a common wastewater 
treatment process, the A/A/O-
MBR process, in different 
geographical locations 
Total community DNA 
Approach: GeoChip 4.0 using 2812 nucleotide 
probes of ARGs 
There was a large diversity of ARGs among the MBRs, with only around 40% of commonly 
detected ARGs worldwide being detected 
There were different dominant ARGs groups in each MBR, with the majority of ARGs being 
derived from Proteobacteria and Actinobacteria 
TN, TP and COD of influent and temperature and conductivity of MLSS were significantly 
correlated to the ARGs distribution in the different MBRs 
Finland 
 
(Karkman et al., 
2016) 
 
 
CAS-Biofilter 
 
 
Assess seasonal variations of 
transposase and ARGs abundance 
in an WWTP utilizing CAS and 
biofilters as tertiary treatment 
Total community DNA  
Approach: gene detection (qPCR array) 
All transposases and 66% of all ARGs assayed were detected in the effluent and nine ARGs 
were enriched in the effluent compared to the influent  
WWTP with tertiary treatment system analyzed substantially decreased the gene abundance 
and richness (>99% reduction) 
Sweden 
 
(Bengtsson-Palme et 
al., 2016) 
 
 
 
 
CAS 
Assess the occurrence of genes 
against antibiotics, biocides and 
metals and their co-selection 
potential in WWTP utilizing the 
CAS process 
 
Total community DNA  
Approach: Metagenomics-Resistome 
Antibiotics: Macrolides, fluoroquinolones, 
tetracyclines, sulfonamides 
Other: Metals, biocides 
No consistent enrichment of ARGs to any particular antibiotic class, for neither biocide nor 
metal resistance genes 
WWTP greatly reduced the number of resistance genes per volume of water, their relative 
abundance per bacterial 16S rRNA was only moderately decreased  
A few resistance genes, including the carbapenemase gene blaOXA-48, were enriched in the 
treatment process 
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Country  
 & Reference 
 
Process/ 
Technology 
Aim(s) Biological target/experimental approach/chemical analyses Study findings 
Italy  
 
(Zanotto et al., 2016) 
 
 
 
CAS-Peracetic acid  
Assess antibiotic resistance 
dynamics over different treatment 
stages (CAS and peracetic acid 
disinfection)  
Isolates: Total coliforms, E. coli resistant to 
ampicillin and chloramphenicol 
Approach: Isolation on chromogenic agar, gene 
detection (PCR) 
Biological process effective in the reduction of the ampicillin and chloramphenicol-resistant 
total coliforms and E. coli by about 2-log units 
No significant decrease of the percentage of ARB through the biological treatment 
Disinfection significantly reduced the ampicillin-resistant E. coli  
China 
 
(Wen et al., 2016) 
1) A2/O 
2) A/O 
3) Cyclic activated 
sludge system 
(CASS) 
4) CASS 
Assess the distribution and 
removal efficiency of ARGs in 
four WWTPs with different 
treatment processes 
Total community DNA  
Approach: gene quantification (qPCR) 
Of all treatment steps, biological treatment played the most important role in ARGs removal, 
followed by UV disinfection  
ARGs were observed in all WWTP effluents after biological treatment process and their 
abundance was still high in the final effluent  
China 
 
(Li et al., 2016) 
1) A2/O 
2) Triple 
oxidation ditch 
Assess antibiotic resistance 
removal in two WWTP with 
different treatment types, 
including UV disinfection 
 
Isolates: Heterotrophic bacteria resistant to 
tetracycline or/and sulfamethoxazole  
Total community DNA 
Approach: Isolation on R2A, gene quantification 
(qPCR) 
Antibiotics: Sulfonamides, tetracyclines, 
trimethoprim 
 
The ARGs were detected in both WWTP effluents 
Biological treatment played the most important role on ARGs and antibiotics removal, and 
physical processes on ARB removal 
UV disinfection did not significantly enhance the removal efficiency 
High concentrations of antibiotics and abundance of ARGs and ARB were detected in the 
excess sludge samples 
China 
 
(Mao et al., 2015) 
 
 
 
 
 
 
CAS--Chlorination 
Assess the removal efficiency of 
ARGs, ARB and antimicrobial 
drugs, in two WWTP utilising 
CAS and chlorine disinfection 
Isolates: Heterotrophic bacteria resistant to 
sulfonamides, tetracyclines, ciprofloxacin and 
erythromycin 
Total community DNA 
Approach: Isolation on nutrient agar, gene detection 
(PCR) and quantification (qPCR) 
Antibiotics: Sulfonamides, trimethoprim, 
tetracyclines, β-lactams, fluoroquinolones, macrolides 
Heavy metals: As, Cd, Cr, Cu, Ni, Pb, Zn 
Bacteria harbouring ARGs persisted through all treatment units, surviving better to 
disinfection by chlorination than total bacteria 
The abundance of ARGs was reduced from the raw influent to the effluent (~90%), although 
high levels of ARGs levels were found in WWTP effluent samples 
The ARGs tetA, tetB, tetE, tetG, tetH, tetS, tetT, tetX, sul1, sul2, qnrB, ermC were 
discharged through the dewatered sludge and plant effluent at higher rates than influent 
values 
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Country  
 & Reference 
 
Process/ 
Technology 
Aim(s) Biological target/experimental approach/chemical analyses Study findings 
USA 
 
(Naquin et al., 2015) 
 
 
 
 
CAS-UV  
Assess the presence of ARGs in a 
small town WWTP utilizing CAS 
followed by UV disinfection 
 
Isolates: Total bacteria 
Total community DNA 
Approach: Isolates on TSA, antibiograms, gene 
detection (PCR), Genetic transformation assay 
(mecA) 
ARGs were present in both raw and treated wastewater during all the sampling periods 
 
Saudi Arabia  
 
(Al-Jassim et al., 
2015) 
 
 
 
 
 
CAS-chlorination 
Assess the efficiency of removal 
of microbial contaminants in a 
WWTP utilizing CAS and 
chlorine disinfection 
Isolates: Total heterotrophic bacteria, total and faecal 
coliforms 
Total community DNA  
Approach: Isolation on nutrient agar, sulfate and 
brilliant green bile lactose and EC, antibiograms (8 
antibiotics), bacterial community analysis, gene 
quantification (qPCR) 
Antibiotics: ampicillin, kanamycin, erythromycin, 
tetracycline, ceftazidime, ciprofloxacin, 
chloramphenicol, meropenem  
16S rRNA gene-based community analysis showed that genera associated with opportunistic 
pathogens (e.g. Acinetobacter, Aeromonas, Arcobacter, Legionella, Mycobacterium, 
Neisseria, Pseudomonas and Streptococcus), were detected in the influent and some were 
found in chlorinated effluent 
The ARGs tetO, tetQ, tetW, tetH, tetZ were also present in the chlorinated effluent 
The proportion of bacterial isolates resistant to 6 types of antibiotics increased from 3.8% in 
the influent to 6.9% in the chlorinated effluent 
6.8% of isolates from influent were resistant to meropenem and 24% of the isolates were 
resistant in the chlorinated effluent 
25% of the isolates in the influent and 28% of isolates in the effluent were resistant to at least 
5 antibiotics  
 
United Kingdom  
 
(Christgen et al., 
2015)  
 
1. Upflow 
anaerobic sludge 
blanket reactor 
(UASB)2. 
Anaerobic hybrid 
reactor (AHR)3. 
Mixed aerobic 
reactor (AER1)  
4. and 5. Anaerobic 
aerobic sequence 
bioreactor (AAS) 
 
Assess ARGs removal in five 
different domestic wastewater 
treatment options 
Total community DNA  
Approach: Metagenomics-Resistome  
The AAS and aerobic treatment achieved a higher removal of certain ARGs (aminoglycoside, 
tetracycline, β-lactam resistance genes) compared to UASB and AHR, indicating the higher 
capacity of the combined system to remove ARGs compared to each process alone  
Sulfonamide and chloramphenicol resistance genes were unaffected by the AAS treatment 
while multi-drug resistance increased from influent to effluent 
Metagenomic data suggested that aerobic processes may be generally better than anaerobic 
processes for reducing ARGs 
Germany 
 
(Alexander et al., 
2015) 
Nitrification-
denitrification-
phosphorus 
elimination 
 
 
Detect and quantify genes and 
gene carriers of clinical 
significance; 
Assess the dissemination of 
ARGs and opportunistic bacteria 
in natural populations; 
Identify and monitor critical 
water systems and potential 
Total community DNA 
Approach: Gene quantification (qPCR), 
quantification of antibiotic residues (LC-MS) 
Antibiotics: (Dehy-)erytromycin, Acetyl-
sulfamethoxazole, chloramphenicol, chlortetracycline, 
clarithromycin, doxicycline, erythromycin, 
metronidazole, oxytetracycline, roxithromycin, 
sulfadiazine, sulfadimidine, sulfamerazine, 
The removal capacities were up to 99% for some WWTPs tested, but not in all investigated 
bacteria; 
The abundance of most ARGs increased in the bacterial population after conventional 
wastewater treatment. As a consequence, downstream surface water and also some 
groundwater compartments displayed high abundances of all four ARGs 
58 
 
Country  
 & Reference 
 
Process/ 
Technology 
Aim(s) Biological target/experimental approach/chemical analyses Study findings 
microbiological risks for human 
health 
trimethoprim 
China 
 
(Xu et al., 2015) 
 
 
 
A/O  
Assess the abundance and 
distribution of antibiotics and 
ARGs in a WWTP utilizing 
anaerobic/anoxic process and in 
its effluent-receiving river. 
Total community DNA 
Approach: gene quantification (qPCR)  
Antibiotics: Tetracyclines, sulfonamides, 
fluoroquinolones 
Concentration of tetracyclines, sulfonamides and quinolones decreased after treatment 
ARGs abundance did not vary over the different treatment stages 
Sulfonamide resistance genes were present at relatively high concentrations in all samples 
 
China  
 
(Zhang et al., 2015b) 
 
 
 
 
CAS 
Assess the antibiotic-resistance 
phenotypes in three WWTP 
utilizing CAS process.  
Isolates: Heterotrophic bacteria and total coliforms 
Total community DNA 
Approach: Isolation on R2A and MacConkey, 
antibiograms (12 antibiotics), gene quantification 
(qPCR) 
The proportion of bacterial isolates resistant to more than 9 antibiotics was lower in effluent 
isolates than in the influent 
Gram-negative bacteria dominated in influent and Gram-positive in effluent 
The ARGs examined had higher prevalence in ARB from the influent than in the effluent, 
except for sulA and blaCTX 
The abundance of ARGs in activated sludge from two of the three plants were higher in 
aerobic compartments than in anoxic ones 
Poland 
 
(Kotlarska et al., 
2015) 
1) A2/O 
2) Primary and 
secondary 
anoxic 
treatment 
Assess the antibiotic resistance 
profiles of E. coli isolated from 
two WWTP, their marine outfalls 
and from a major tributary of the 
Baltic Sea, in order to evaluate 
the role of the studied wastewater 
effluents and tributaries in the 
dissemination of integrons and 
ARGs. 
Isolates: E. coli  
Total community DNA 
Approach: Isolation on mFC agar, antimicrobial 
susceptibility tests, gene detection (PCR), sequencing 
of gene cassette arrays 
  
Ampicillin-resistant E. coli were the most frequently observed bacteria (<32%)  
32% and 3.05% of the isolates were positive for class 1 and 2 integrons, respectively 
The presence of integrons was associated with increased frequency of resistance to 
fluoroquinolones, trimethoprim/sulfamethoxazole, amoxicillin/clavulanate, 
piperacillin/tazobactam and MDR-resistance phenotype.  
The most predominant gene cassette arrays were dfrA1-aadA1, dfrA17-aadA5 and aadA1 
China 
 
(Du et al., 2015) 
 
 
 
A2/O-MBR  
Assess the variation of ARGs 
throughout a A2/O-MBR 
wastewater treatment process  
Total community DNA  
Approach: Gene quantification (qPCR) 
ARGs concentrations decreased in the anaerobic and anoxic effluent but increased in the 
aerobic effluent and sharply declined in MBR effluent 
The reduction in tetW, intI1 and sul1 was positively correlated with the variation of the 16S 
rRNA gene abundance  
ARGs concentrations reduced in the effluent samples as: sul1>intI1>tetX>tetG>tetW 
All ARGs concentrations were higher in spring compared to other seasons 
Spain 
 
(Rodriguez-Mozaz et 
al., 2015) 
 
 
 
CAS 
Assess the variation of antibiotics 
concentration and ARGs 
abundance in urban and hospital 
effluent from a WWTP utilizing 
CAS treatment 
Total community DNA 
Approach: Gene quantification (qPCR) 
Antibiotics: 62 antibiotics 
ARGs copy numbers of blaTEM, qnrS, ermB and sul1 were highest in hospital effluent and 
WWTP influent 
The copy number of ARGs decreased significantly in WWTP effluents but this reduction was 
not uniform across ARGs 
Prevalence of ermB and tetW decreased after WWTP treatment but blaTEM, qnrS and sul1 
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Technology 
Aim(s) Biological target/experimental approach/chemical analyses Study findings 
prevalence increased 
Estonia and Finland 
 
(Laht et al., 2014) 
 
 
 
 
CAS-Secondary 
sedimentation 
 
Assess the role of three WWTP 
utilizing CAS followed by 
tertiary disinfection in the 
distribution of ARGs 
Total community DNA  
Approach: Gene quantification (qPCR) 
sul1, sul2, and tetM were detected in all samples while statistically significant differences 
between the influent and effluent were detected in only four cases 
The purification process caused no significant change in the relative abundance of ARGs, 
while the raw abundances fell by several orders of magnitude  
Standard water quality variables (BOD7, TP and TP, etc.) were weakly related or unrelated to 
the relative abundance of ARGs 
China 
 
(Yang et al., 2014)  
 
 
 
 
CAS Study the fate of ARGs in a 
WWTP utilizing CAS process 
Total community DNA  
Approach: Metagenomics-resistome 
271 ARGs subtypes belonging to 18 ARGs types were identified by the broad scanning of 
metagenomics analysis 
Influent had the highest ARGs abundance, followed by effluent, anaerobic digestion sludge 
and activated sludge 
78 ARGs subtypes persisted through the biological wastewater and sludge treatment process 
Significant correlation between specific bacterial genera, included potential pathogens, and 
the distribution of ARGs were observed  
China 
 
(Su et al., 2014) 
1) CAS -
chlorination 
2) CAS-oxidation 
ditch-UV 
disinfection 
Assess the effect of treatment on 
antibiotic resistance profiles in 
two WWTP utilizing: a) CAS 
followed by chlorine disinfection 
and b) oxidation ditch followed 
by UV disinfection 
 
Isolates: E. coli resistant to quinolones and β -
 lactams 
Approach: Isolates on nutrient agar, modified mTEC 
agar, antibiograms (12 antibiotics), gene detection 
(PCR) 
Antibiotics: ampicillin, piperacillin, cefazolin, 
ceftazidime, gentamycin, streptomycin, ciprofloxacin, 
levofloxacin, sulfamethoxazole/trimethoprim, 
trimethoprim, tetracycline, chloramphenicol 
98.4% of the isolates were resistant to the examined antibiotics and 90.6% were resistant to at 
least 3 antibiotics  
The number of the total cultivable bacteria and E. coli decreased after treatment  
Disinfection significantly reduced total bacteria but not ARB prevalence 
 
 
Portugal 
 
(Novo et al., 2013) 
 
 
 
 
CAS 
Assess the influence of abiotic 
factors on the levels of antibiotic 
resistance and bacterial structure 
community of the CAS-treated 
final effluent 
Isolates: Heterotrophic bacteria, enterobacteria and 
enterococci resistant to amoxicillin, tetracycline, 
ciprofloxacin and sulfamethoxazole 
Approach: Isolates on PCA, m-FC and m-Ent, 
genotyping (DGGE) 
Antibiotics: Tetracyclines, β-lactams, sulfonamides, 
The bacterial community was distinct in raw and in treated wastewater  
In Autumn, but not in Spring, amoxicillin and ciprofloxacin resistance prevalence increased 
significantly after wastewater treatment while temperature was positively correlated with the 
prevalence of sulfonamide resistant heterotrophs and enterobacteria in treated wastewater 
The concentration of tetracyclines, penicillins, sulfamides and quinolones and the abundance 
of antibiotic-resistant cultivable bacteria in the raw wastewater were positively correlated 
with the abundance of Epsilonproteobacteria in treated wastewater and negatively with 
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Technology 
Aim(s) Biological target/experimental approach/chemical analyses Study findings 
fluoroquinolones 
Metals: Cd, Pb, Cr, As and and Hg 
Other: Triclosan 
Gamma-, Betaproteobacteria and Firmicutes 
China 
 
(Chen and Zhang 
2013) 
 
 
CAS, constructed 
wetlands (CWs), 
MBRs 
Assess the occurrence and 
removal of tet and sul resistance 
genes in 12 wastewater treatment 
systems with different treatment 
capacities and treatment 
processes including CAS, 
constructed wetlands and MBRs 
Total community DNA  
Approach: gene quantification (qPCR) 
Significant correlation between the gene copy numbers and wastewater receiving capacity 
were observed 
Statistical analysis revealed a positive correlation between the gene copy numbers of sul1 and 
intI1, whereas the gene numbers of tetM and sul1 were strongly correlated with 16S rRNA 
gene 
Spain 
 
(Sidrach-Cardona and 
Bécares 2013) 
Seven CWs of 
different types Evaluate removal of antibiotic 
resistant bacteria from urban 
wastewater by CWs with 
different design  
Isolates: E. coli, Coliforms and Enterococcus 
Approach: Isolates on coliform agar and SB agar 
Antibiotics: amoxicillin, azithromycin, 
amoxicillin+clavulanic acid, and doxycycline 
 
Removal efficiency 90 and 99%. 
Better results for Sub-surface ﬂow CW, planted with Phragmites spp. 
Design parameters inﬂuencing their performance, those with sub-surface ﬂow proving better 
than hydroponic, and planted better than unplanted 
Estónia 
 
(Nolvak et al., 2013) 
Pilot system 
consisted of a septic 
tank, followed by 
six parallel vertical 
subsurface ﬂow 
mesocosms, a 
collection well, and 
21 parallel HSSF 
MCs 
Evaluate removal of antibiotic 
resistant genes from municipal 
wastewater by CWs with 
different design  
Total community DNA  
 
antibiotic resistance genes  
Antibiotic: tetracyclines, macrolides, sulfonamides, 
penicillins, and ﬂuoroquinolones 
In general, the proportions of different ARGs decreased in mesocosm efﬂuent bacterial 
communities (compared to the inﬂuent) during the treatment process – no percentages 
removal given 
Antibiotic resistance genes in the wetland media bioﬁlm and in efﬂuent were affected by 
system operation parameters, especially time and temperature 
China 
 
(Chen et al., 2015) 
 four surface and 
subsurface flow-
CWs, and a 
stabilization unit 
Evaluate removal of antibiotic 
resistant genes from rural 
domestic wastewater by CWs 
with different design 
Total community DNA  
antibiotics leucomycin, ofloxacin, lincomycin, and 
sulfamethazine 
>99% in total 
CW3 with 43.6%, followed by CW2 (27.5%), CW1 (11.9%), and CW4 (11.9%). The least 
contributing treatment unit was CW5, with a contributing rate of 2.6 % Sorption onto soil or 
medium and biodegradation are two main mechanisms for ARGs elimination in the ICW 
system. 
China 
(Chen et al., 2016) 
Six mesocosm-
scale CWs 
Evaluate removal of antibiotic 
resistant genes Raw domestic 
sewage by CWs with different 
design 
Total community DNA  
12 genes including three sulfonamide resistance genes 
(sul1, sul2 and sul3), four tetracycline resistance 
genes (tetG, tetM, tetO and tetX), two macrolide 
resistance genes (ermB and ermC), two 
chloramphenicol resistance genes (cmlA and ﬂoR) 
Removal efficiency between 63.9 and 84.0% 
HSSF-CWs and VSSF-CWs showed higher removals of pollutants than the SF-CWs Planting 
in the CWs was beneﬁcial to pollutant removal. Mass removals attributed to biodegradation, 
substrate adsorption, and plant uptake. 
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6. WWTPs design, operation and upgrading for CEC removal: techno-economical evaluations 
6.1 Impact of CEC removal implementation on WWTPs design and operation 
As pointed out in the previous sections, the effect of wastewater treatment on the fate of CEC 
occurring in wastewater depends on different factors including: (i) wastewater characteristics, (ii) 
initial concentration of target CEC, (iii) size of WWTPs, (iv) type of biological process/technology, 
(v) operating conditions of biological process/technology and (vi) presence of tertiary and/or 
advanced treatment. Wastewater characteristics also depend on the size of the WWTP because large 
WWTPs (e.g., > 50,000 – 60,000 PE) often collect hospital and industrial wastewater, while small 
WWTPs (SWWTPs, < 3,000 – 5,000 PE), particularly those in remote and/or rural area, are not or 
little affected by this kind of wastewaters. Moreover, treatment methods in medium/large WWTPs are 
basically different compared to small WWTPs. In medium/large WWTPs, CAS, MBRs or MBBRs 
are typical options for secondary (biological) treatment, while for small WWTPs (in particular for 
those in the low range of PE (e.g. < 1,000-2,000) some options may be not sustainable in terms of 
investment and management costs (e.g., MBRs) and cheaper solutions may be used (e.g., CWs, 
rotating biological contactors, Imhoff tanks, etc.).  
Achieving CEC removal through optimization of existing WWTPs will vary between different 
treatment processes, but in general it will be based on adjustment of the operational process 
parameters typically proposed in the literature (Omil et al., 2010; Li et al., 2015; Tiwari et al., 2017) 
as well as of those, mentioned in early sections, which affect pollutants removal: 
- Increased SRT to enhance biodegradation of typically moderately biodegradable compounds 
through microbial community diversification due to increased growth of slow growing 
microorganisms such as nitrifying bacteria at longer SRTs (Holbrook et al., 2002; Stephenson and 
Oppenheimer 2007; Tiwari et al., 2017). Although SRT of above 15 days are typically 
recommended (Li et al., 2015), different CEC may require different SRTs for achieving optimal 
removal rate. Nevertheless, operation at very high SRT to promote extra biological transformation 
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will lead to higher operating costs due to higher oxygen requirements of biomass (Krzeminski et 
al., 2017). 
- Increased HRT to improve removal of compounds that are moderately biodegradable (high kbiol) 
and have low sorption potential (low Kd) (Eggen and Vogelsang 2015). Enhanced CEC removal in 
CAS has been reported at HRT of above 16 hours (Guerra et al., 2014). However, HRT also 
increases capital costs while CEC removal improvement at higher HRT is still debated (Taheran 
et al., 2016).  
- Increased MLSS to enhance biodegradation provided by high biological activity per unit volume 
leading to generation of slow-growing bacteria able to degrade certain biologically-recalcitrant 
pollutants (Bernhard et al., 2006; Sipma et al., 2010; Clouzot et al., 2011; Tran et al., 2013).  
- Implementation of nutrient removal stages associated with varying redox conditions (nitrification 
and de-nitrification) leading to increased microbial diversity, broad enzymatic range and 
microorganisms’ activity. Heterotrophic microbes are of importance for fast biodegradable 
compounds whereas lithotrophic ammonia oxidizers and nitrifyers are of importance for slowly 
biodegradable compounds (Tran et al., 2013). In particular, presence of anoxic zones and high 
ammonia loading rates seems to favour CEC removal in CAS (Li et al., 2015). 
- Presence of fat during primary treatment that favours absorption of lipophilic compounds with 
high Kow such as musks (Li et al., 2015). 
- Combination of different processes, such as CAS and CWs, or combination of CWs with different 
designs, as varying redox conditions should significantly improve pollutants removal. 
The possibility of establishing favourable operating conditions for CEC removal is different for 
large/medium WWTPs and small WWTPs. For example, in CAS process, large WWTPs are operated 
with high organic loading rate (> 0.5 kg BOD5/(kg MLVSS×d)), which typically results in designing 
aeration/nitrification tank with relatively low hydraulic retention time (HRT, 6 – 12 h) and sludge 
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retention time (SRT, 3 – 6 d). Differently, CAS process in SWWTPs is typically designed to operate 
under extended aeration conditions (< 0.05 kg BOD5/(kg MLVSS×d), which results in larger 
aeration/nitrification tank (HRT= 36 – 48 h, SRT= 30 – 40 d) (Metcalf and Eddy 2003). 
Other factors influencing CEC removal often mentioned in the literature, such as temperature, content 
of organic matter, ionic strength and conductivity, were considered less realistic for implementation at 
the full-scale, and thus not discussed further.  
6.2 Feasibility of WWTPs upgrading to remove CEC  
Possible solutions to successfully minimize the release of CEC into the environment from WWTPs 
effluents consist of implementation of an effective tertiary treatment, upgrading through re-designing 
of the existing treatment processes or optimizing operating conditions of the existing biological 
process according to the flow chart reported in Figure 1.  
 
Figure 1: Flow chart for decision making on upgrading conventional WWTPs for CEC removal 
 
The likelihood of implementation of dedicated treatment for CEC removal depends not only on the 
performance aspects of particular process such as removal efficacy and removal mechanisms, range of 
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treated pollutants and reliability of removal efficiency, but also on significant number of other factors. 
Among these impact factors, ease of construction and set-up, simplicity of operation and maintenance 
requirements, flexibility in adapting to the fluctuations in influent flowrate and characteristics, capital 
and operating costs, cost-effectiveness, environmental friendliness in respect to waste production and 
disposal needs, overall environmental footprint, associated prospects and constraints, development 
stage, level of social acceptance, and finally who is supposed to cover the costs of dedicated CEC 
treatment are mentioned (Eggen and Vogelsang 2015; Bui et al., 2016; Tiedeken et al., 2017).  
However, proper economic comparison between different treatment alternatives discussed in this 
review is very difficult due to scarce information in the literature (Bolzonella et al., 2010; Fatone 
2010; Krzeminski et al., 2017) and because each treatment design is unique due to its specific site 
conditions and operating settings/conditions. The capital and operating costs depend on number of 
parameters such as scale of treatment, feed water characteristics, targeted pollutants, desired water 
quality and electricity, chemicals and personnel costs, which vary from country to country (Bui et al., 
2016; Taheran et al., 2016).  
Furthermore, holistic assessment of different alternatives taking into account environmental impacts 
is needed to quantify benefits of CEC removal. Approaches, such as Life Cycle Assessment 
(Corominas et al., 2013), nonmarket valuation (Kotchen et al., 2009; Logar et al., 2014) and distance 
function approach based on shadow prices, to quantify environmental benefits from reduced 
discharges of CEC (Molinos-Senante et al., 2013) have been proposed (Schröder et al., 2016; 
Tiedeken et al., 2017). For example, research findings of the LCA studies review (Corominas et al., 
2013) indicate that in general environmental benefits do not outweigh the costs of advanced treatment 
implementation. However, LCA studies evaluating secondary treatment alternatives for the removal 
of CEC to the best authors’ knowledge have not been published.  
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Alternatively, in cases when the implementation costs would outweigh the environmental benefits, or 
if cost would be considered too great, existing WWTPs could be optimized for CEC removal (Jones et 
al., 2007) by adjusting operating parameters reported in the previous section.  
6.3 Techno-economical comparison of the selected technologies 
To define the technology to be implemented for achieving a more effective removal of the selected 
CEC and producing effluents suitable for re-use, a comparison of the proposed technological 
solutions, summarizing the data reported in the manuscript, is reported in Table 8. In order to achieve 
an integrated, coherent comparative efficiency assessment of the examined technologies, besides the 
achievable removal efficiencies, other evaluation parameters such as complexity in lay out and 
management, scale of application and need of a post-treatment are included. It is worth noting that 
updated specific quantitative cost data related with CEC removal in discussed secondary treatment 
processes are not available in scientific literature, thus a qualitative evaluation based on the literature 
review has been performed, where some important economic factors (i.e. energy and chemical 
consumptions) are being discussed. 
In addition, with the objective to give a first simplified comparative evaluation of the technologies, a 
score was assigned in a scale from 1 to 4, where 1 is the worst and 4 is the best evaluation of each 
technology, according to each examined parameter. The score was determined based on the available 
technical data elaborated for the purposes of this review.  
The ARB&ARGs removal figures are not reported in Table 8 because data available is scarce and not 
following a systematic protocol of analyses, leading to results biased by large variability in the nature 
of approaches reported in the existing in scientific literature so far. Majority of studies examines 
prevalence of resistance in selected isolated colonies and does not focus on the removal of 
ARB&ARGs as such. In addition, many studies report removal efficiencies at the end of the WWTP 
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which may involve a tertiary or disinfection step and do not provide data on the actual biological 
process removal efficiency.  
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Table 8. Techno-economical comparative evaluation of the proposed technologies to produce effluents suitable for reuse. Data for the 
different groups of CEC are with reference to the ones included in this review. A score assigned in a scale from 1 to 4 (where 1 is the worst 
and 4 is the best evaluation of each technology according to the examined parameter) is reported in parentheses.  
Parameter Group of compounds Technology CAS MBR MBBR CW 
Range of removal 
efficiencies (%) 
Pharmaceuticals  <0 – 90 <0 – 99  0 – 100  0 – 99 
Antibiotics <0 – 90 <0 – 99  <0 – 96 0 – 100  
PCPs 30 – 55 N.A. N.A. N.A. 
Estrogens 18 – 96 20 – 100  65 – 100  0 – 100 
Neonicotinoids 11 – 18 N.A. N.A. N.A. 
Pesticides N.A. N.A. N.A. N.A. 
Industrial chemicals <0 – 100 <0 – 94  43 – 76  8 – 100 
Need of post-treatment  YES  NO YES YES/NO 
Complexity in lay out/Ease of construction    Simple lay out  
(4) 
 Commercially available, 
TRL=9 
(4) 
 Commercially 
available and 
simpler than CAS 
(2 -3) 
 Ease of construction 
 Commercially 
available 
(4) 
Complexity in operation  Easy management not 
requiring complex 
control systems  
(4) 
 High process 
automation 
 Skilled staff needed 
(2-3) 
 Easy management  
 Needs maintenance 
 (retention grids of 
media) 
 Simpler than CAS 
(2-3) 
 Easy management 
 Needs maintenance 
(3) 
Flexibility   Low flexibility due to 
high inertia of the system 
in changing operating 
conditions  
(1) 
 High, modular system 
(4) 
 Good flexibility 
(media addition / 
HYBAS system) 
(3) 
 Low flexibility, not 
possible to change 
design 
(2) 
Reliability  Not resilient to 
permanent inflow 
variation  
 Not resilient to influent 
shock load  
(1-2) 
 Stable effluent 
 Resilient to inflow 
fluctuations 
 Relatively resilient to 
shocks  
(3-4) 
 Stable effluent 
 Very resilient to 
flow fluctuation 
 Very resilient to 
shock loads 
(3) 
 Relatively resilient to 
flow fluctuation 
 Relatively resilient to 
shock loads 
 Can be dependent on 
temperature 
(seasonality effect) 
(2) 
Footprint  Large footprint  
(1) 
 Small footprint 
 Space reduction 
possible 
 Larger/similar to 
MBRs and less 
than CAS and 
 Large areas required 
(2) 
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Parameter Group of compounds Technology CAS MBR MBBR CW 
(4) CWs 
                   (3) 
 
Environmental aspects (waste production, 
disposal, chemicals) 
 Production of sludge 
containing residual CEC  
(2) 
 Treatment of 
concentrate and sludge 
containing CEC 
(3) 
 Low sludge 
production but 
containing residual 
CEC  
 Less sludge than 
CAS. 
 Carriers have very 
long lifetime 
(3) 
 
 Need previous 
filtration step to 
prevent clogging 
 Might need post 
treatment to remove 
some recalcitrant CEC 
(3) 
Investment cost  Lower than MBRs and 
MBBRs 
(4) 
 Typically, higher than 
CAS 
 Membrane cost ca. 40-
60% of total capital 
costs  
(2) 
 Higher than CAS 
and CWs, but less 
than MBRs 
(2-3) 
 Reduced costs 
compared to CAS 
(4) 
Management cost  Energy 0.2-1.4 kWh/m3 
(4) 
 Energy 0.4-4.2 kWh/m3 
 Membrane replacement 
ca. 10-14% of total 
operation costs  
 Chemicals for 
membrane cleaning 
 (2) 
 Slightly higher 
aeration than CAS 
needed.  
 Less than MBRs, 
more than CWs 
and CAS  
(3) 
 
 Reduced costs 
compared to CAS 
(4) 
 
Legend: N.A. – not available;  
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7. Future perspectives and research needs 
Despite significant research and monitoring efforts devoted to presence and fate of CEC, data on 
occurrence and/or removal of some of the emerging compounds are not available. Nevertheless, this 
review shows the potential of four secondary biological treatment technologies for the removal of 
selected CEC and the need to reach effluent quality suitable for reuse of treated water for e.g. 
irrigation purposes. This in turn, allows defining the research needs for the analysed technologies in 
respect to the removal of CEC. 
CAS process is the most investigated process for the removal of CEC. However, the conventional 
layout (i.e. aerobic process) is ineffective, while operation at high SRT or with sequential anoxic-
aerobic phases can ameliorate their performance for some pharmaceutical compounds. Thus, 
research should be devoted to the optimization of the process performance by modifying the 
operating parameters (when possible), and/or investigating the combination with more powerful 
technologies to be applied as tertiary treatment.     
MBR technology has been extensively investigated for the removal of CEC, but the mechanisms 
have not yet been fully unravelled. Further research is needed to understand removal mechanisms of 
the CEC and microbiological contaminants such as ARB&ARGs. For example, fouling layer 
interaction and the role of deposits on the membrane surface as potential additional barrier increasing 
CEC removal is needed. In addition, identification of CEC removing bacterial species and/or 
enzymes, unravelling optimal operating conditions, and elucidation of the metabolites produced 
during MBR treatment is required. These products may possess different structural characteristics 
compared to the parent compounds, making them toxic once they are filtered and end up in the 
clarified MBR effluent. Finally, cost-effective integrated MBR systems providing synergistic effects 
of combined technologies, should be further developed with emphasis on system optimization, 
scaling up, and full-scale validation.  
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The removal of chemical and microbial CEC by CWs is a recent area of study, and current CWs are 
not able to effectively eliminate CEC from wastewater. Therefore, more research is needed to 
identify the feasibility for full-scale applications. The efficiency of the processes occurring in CWs 
depends primarily on the operation mode, design, type of substrate and the presence and type of 
plants. Therefore, studies should be designed to reveal the effect of each process on CEC. Only with 
that information one can optimize CWs design and operating parameters, consequently getting better 
treatment efficiency and fully supporting CWs utility. In addition, the effectiveness of the processes 
in the CWs can be increased by the use of hybrid systems that combine CWs of different designs in 
series or by combining CWs with other processes e.g. solar driven homogeneous advanced oxidation 
processes (e.g., sunlight mild photo Fenton, sunlight/H2O2). As CWs have some specific 
prerequisites, such as large areas requirements and the fact that it can be dependent on temperature 
(seasonality effect), their application is site dependant. 
The number of wastewater treatment plants designed using the MBBR technology as the main 
secondary treatment process around the world is estimated by Veolia to be between 20 and 50, 
mainly in Scandinavia, China and the United States. Even less studies investigated the fate of CEC 
throughout the process treatment at full-scale. The added value of biofilm for the elimination of CEC 
still needs to be investigated in laboratory scale and up-scaled to real applications. The global 
understanding of CEC removal pathways (including diffusion into the biofilm, hydrodynamics 
conditions) and regulation of bacterial communities on biofilm (through biofilm thickness) should be 
in the scope of new research projects. The occurrence of the highly active biomass in the biofilm in 
the later stages of MBBR treatment trains could be positive for the removal of recalcitrant organic 
CEC, but the generally achieved thin biofilm contains too little biomass to complete the CEC 
degradation in a realistic contact time. This experimental evidence suggests that research should aim 
to increase the available biomass retained in these parts of the MBBR treatment train while retaining 
the efficient biomass. In this paper, MBBR technology was studied as the secondary treatment. 
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However, MBBR as a tertiary treatment should also be considered as an interesting advanced 
treatment technology for recalcitrant CEC removal. 
However, regardless of the applied technology, the removal of CEC depends on the treatment 
conditions and the physicochemical properties of the individual compounds. Furthermore, the current 
knowledge suggests that the factors that rule the fate of ARB&ARGs are complex and variable 
among different WWTP, making each plant a unique microbial ecosystem. Therefore, it is still 
difficult to assess the CEC impact onto the wastewater receiving environments, as well as the 
potential ways in which CEC removal can be enhanced. This highlights the need for research to 
maximize CEC removal by biological processes while successfully removing conventional 
parameters (namely, BOD, COD, nitrogen, phosphorus, etc.) to promote a safer reuse of treated 
wastewater. 
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